Public dataset
Recorded source agreement and disagreement
Show whether sources print one normalized reading, have incompatible units, lack structured comparison context, or contain a context-matched numeric difference.
- Public rows
- 1,681
- Generated
- Schema version
- source-consensus/2
Coverage
What this run contains
- Compared medicine fields
- 1,681
- Agree
- 1,282
- Differ
- 0
- Not comparable
- 12
- Insufficient context
- 387
- Fields represented
- 5
- bioavailability, halfLife, proteinBinding, tMax, volumeOfDistribution
Method
How the rows were made
- Deterministic rules normalize recorded pharmacokinetic readings and compare only like-for-like values.
- One normalized printed reading may be agree even when clinical context was not extracted; this reports printed-reading agreement only.
- Distinct readings may differ only when their units and denominators are comparable and one matching, non-placeholder population/formulation context was structurally extracted. Otherwise they are insufficient_context.
- not_comparable preserves incompatible units or denominators instead of guessing. insufficient_context preserves missing or non-matching structured context instead of manufacturing agreement or disagreement.
- The agreement rate describes the distribution of recorded source readings; it is not a probability that a value is true.
- Every distinct printed reading retains its unit, population context, source count, and complete source records. The API paginates field rows, never child readings or sources.
- documentsExamined is every matching single-substance archive document inspected for that medicine. The generator has no document, reading, or source ceiling, so there is no hidden available-versus-retained remainder.
Limits
Read these before using a row
- Current label parsing does not structurally extract population or formulation context. Distinct otherwise-comparable readings are therefore insufficient_context, never differ; agree may mean printed-reading agreement only. Source records are complete but are not independent-experiment counts.
- The current deterministic parser does not structurally extract population or formulation context from these sentences. It records that context as unknown and cannot publish distinct same-unit readings as differ.
- Neither reading is marked wrong. Population, formulation, route, and other unextracted context may explain the printed difference.
- Only the recorded fields and source documents in this snapshot are compared.
- A source count is the number of retained source records in the row, not a count of independent experiments.
Provenance
Source examples
abacavir · bioavailability · agree
15 documents examined; 83% (Unknown: population and formulation context were not structurally extracted from this source sentence.)
FDA_LABEL:5676d391-f9a4-44be-9604-954b3d8d0e2b (opens source in a new tab)The geometric mean absolute bioavailability of the tablet was 83%.
alemtuzumab · volumeOfDistribution · not_comparable
2 documents examined; 0.18 L/kg (Unknown: population and formulation context were not structurally extracted from this source sentence.); 14.1 L (Unknown: population and formulation context were not structurally extracted from this source sentence.)
FDA_LABEL:4f5f7255-7abc-4328-bd1a-ceaf139ef3e0 (opens source in a new tab)Distribution After the last 30 mg dose, the mean volume of distribution at steady-state was 0.18 L/kg (range 0.1 to 0.4 L/kg).
abiraterone · halfLife · insufficient_context
31 documents examined; 12 ± 5 hours (Unknown: population and formulation context were not structurally extracted from this source sentence.); 18 hours (Unknown: population and formulation context were not structurally extracted from this source sentence.)
FDA_LABEL:c9eb9b46-f847-40a8-802c-a51b40406d5a (opens source in a new tab)Elimination In patients with metastatic CRPC, the mean terminal half-life of abiraterone in plasma (mean ± SD) is 12 ± 5 hours.
Artifact used for this view: data/source-consensus.ndjson. The reader resolves the current run first and uses the checked-in compatibility run only when a current artifact is absent.
Schema
Fields in the public projection
| Field | Type | Meaning |
|---|---|---|
| medicineSlug | string | Stable RNAWiki medicine route key. |
| field | string | Recorded pharmacokinetic field being compared. |
| comparisonState | string | agree (printed-reading agreement), differ (context-matched comparable disjoint values), not_comparable (unit/denominator mismatch), or insufficient_context. Every state remains declared even when its current count is zero. |
| comparisonReasons | string[] | Deterministic codes explaining the state. |
| documentsExamined | number | Recorded source documents considered for the field. |
| sourceCount | number | Recorded source readings represented. |
| agreementRate | number | Share represented by the leading normalized printed-reading group; not a confidence score or clinical agreement probability. |
| readings | consensus-reading[] | Complete, untruncated reading groups. Each keeps the printed display, numeric value when parsed, unit, population context, source count, and every source identity, version/effective date or explicit absence, retrieval date, locator, safe link, and excerpt. |
Reader
Search and filter the rows
Showing 1,441–1,450 of 1,681 matching rows. Filters and search terms remain attached when you move between pages or open the API view.
Projected row 1441
- Medicine slug
- tacrolimus
- Compared field
- bioavailability
- Comparison state
- insufficient_context
- Reason codes
- STRUCTURED_CONTEXT_MISSING
- Documents examined
- 44
- Source count
- 40
- Agreement rate
- 0.95
- Recorded readings
17±10%
- Numeric value
- 17
- Unit
- %
- Source records
- 38
Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.
Show all 38 source records
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:61dee012-43af-0e9a-3843-9b9b91e022c4 (opens source in a new tab)
Tacrolimus label
Version not recorded · Effective date not recorded
The absolute bioavailability of tacrolimus was 17±10% in adult kidney transplant patients (N=26), 22±6% in adult liver transplant patients (N=17), 23±9% in adult heart transplant patients (N=11) and 18±5% in healthy volunteers (N=16).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:98e0584d-16d2-442b-86ce-e5e65239db0c (opens source in a new tab)
Tacrolimus label
Version not recorded · Effective date not recorded
The absolute bioavailability of tacrolimus was 17±10% in adult kidney transplant patients (N=26), 22±6% in adult liver transplant patients (N=17), 23±9% in adult heart transplant patients (N=11) and 18±5% in healthy volunteers (N=16).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:759cf905-7406-4d1b-a1a8-10068cb11f04 (opens source in a new tab)
Tacrolimus label
Version not recorded · Effective date not recorded
The absolute bioavailability of tacrolimus was 17 ± 10% in adult kidney transplant patients (N = 26), 22 ± 6% in adult liver transplant patients (N = 17), 23 ± 9% in adult heart transplant patients (N = 11) and 18 ± 5% in healthy volunteers (N = 16).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:ed7d1495-3585-409d-94f1-b3d2469d222c (opens source in a new tab)
Tacrolimus label
Version not recorded · Effective date not recorded
The absolute bioavailability of tacrolimus was 17 ± 10% in adult kidney transplant patients (N = 26), 22 ± 6% in adult liver transplant patients (N = 17), 23 ± 9% in adult heart transplant patients (N = 11) and 18 ± 5% in healthy volunteers (N = 16).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:7f667de1-9dfa-4bd6-8ba0-15ee2d78873b (opens source in a new tab)
Tacrolimus label
Version not recorded · Effective date not recorded
The absolute bioavailability of tacrolimus was 17 ± 10% in adult kidney transplant patients (N = 26), 22 ± 6% in adult liver transplant patients (N = 17), 23 ± 9% in adult heart transplant patients (N = 11) and 18 ± 5% in healthy volunteers (N = 16).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:10ceb3bc-11cc-13e4-e063-6394a90acce4 (opens source in a new tab)
Tacrolimus label
Version not recorded · Effective date not recorded
The absolute bioavailability of tacrolimus was 17±10% in adult kidney transplant patients (N=26), 22±6% in adult liver transplant patients (N=17), 23±9% in adult heart transplant patients (N=11) and 18±5% in healthy volunteers (N=16).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:93d03943-0655-44f6-b494-57bd1e336a34 (opens source in a new tab)
Tacrolimus label
Version not recorded · Effective date not recorded
The absolute bioavailability of tacrolimus was 17±10% in adult kidney transplant patients (N=26), 22±6% in adult liver transplant patients (N=17), 23±9% in adult heart transplant patients (N=11) and 18±5% in healthy volunteers (N=16).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f21115e2-1d02-4bce-9c13-bf593a52a12f (opens source in a new tab)
Tacrolimus label
Version not recorded · Effective date not recorded
The absolute bioavailability of tacrolimus was 17±10% in adult kidney transplant patients (N=26), 22±6% in adult liver transplant patients (N=17), 23±9% in adult heart transplant patients (N=11) and 18±5% in healthy volunteers (N=16).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:bd447ffa-9196-4c3c-accf-5adf29b84665 (opens source in a new tab)
Tacrolimus label
Version not recorded · Effective date not recorded
The absolute bioavailability of tacrolimus was 17 ± 10% in adult kidney transplant patients (N = 26), 22 ± 6% in adult liver transplant patients (N = 17), 23 ± 9% in adult heart transplant patients (N = 11) and 18 ± 5% in healthy volunteers (N = 16).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:5f742224-618e-4f4c-bdec-7693be99c697 (opens source in a new tab)
Tacrolimus label
Version not recorded · Effective date not recorded
The absolute bioavailability of tacrolimus was 17 ± 10% in adult kidney transplant patients (N = 26), 22 ± 6% in adult liver transplant patients (N = 17), 23 ± 9% in adult heart transplant patients (N = 11) and 18 ± 5% in healthy volunteers (N = 16).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:3519febc-c9df-4559-b07a-92f8b0c7e770 (opens source in a new tab)
Tacrolimus label
Version not recorded · Effective date not recorded
The absolute bioavailability of tacrolimus was 17 ± 10% in adult kidney transplant patients (N = 26), 22 ± 6% in adult liver transplant patients (N = 17), 23 ± 9% in adult heart transplant patients (N = 11) and 18 ± 5% in healthy volunteers (N = 16).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:bd9fea26-0236-d437-c7df-4b7636210875 (opens source in a new tab)
Tacrolimus label
Version not recorded · Effective date not recorded
The absolute bioavailability of tacrolimus was 17 ± 10% in adult kidney transplant patients (N = 26), 22 ± 6% in adult liver transplant patients (N = 17), 23 ± 9% in adult heart transplant patients (N = 11) and 18 ± 5% in healthy volunteers (N = 16).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:27154d3a-eec5-4000-a4ff-bfbfe27eb806 (opens source in a new tab)
Tacrolimus label
Version not recorded · Effective date not recorded
The absolute bioavailability of tacrolimus was 17±10% in adult kidney transplant patients (N=26), 22±6% in adult liver transplant patients (N=17), 23±9% in adult heart transplant patients (N=11) and 18±5% in healthy volunteers (N=16).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:450c3e32-6d91-4508-b064-49b293e86cec (opens source in a new tab)
Tacrolimus label
Version not recorded · Effective date not recorded
The absolute bioavailability of tacrolimus was 17 ± 10% in adult kidney transplant patients (N = 26), 22 ± 6% in adult liver transplant patients (N = 17), 23 ± 9% in adult heart transplant patients (N = 11) and 18 ± 5% in healthy volunteers (N = 16).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:45af3eda-caaa-4478-9372-95aa65adc9b3 (opens source in a new tab)
Tacrolimus label
Version not recorded · Effective date not recorded
The absolute bioavailability of tacrolimus was 17 ± 10% in adult kidney transplant patients (N = 26), 22 ± 6% in adult liver transplant patients (N = 17), 23 ± 9% in adult heart transplant patients (N = 11) and 18 ± 5% in healthy volunteers (N = 16).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:55467f4b-8437-43a3-b6d9-1bc2a13b4c11 (opens source in a new tab)
Tacrolimus label
Version not recorded · Effective date not recorded
The absolute bioavailability of tacrolimus was 17±10% in adult kidney transplant patients (N=26), 22±6% in adult liver transplant patients (N=17), 23±9% in adult heart transplant patients (N=11) and 18±5% in healthy volunteers (N=16).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:3e8bc65e-8048-4073-8e45-570330603000 (opens source in a new tab)
Tacrolimus label
Version not recorded · Effective date not recorded
The absolute bioavailability of tacrolimus was 17±10% in adult kidney transplant patients (N=26), 22±6% in adult liver transplant patients (N=17), 23±9% in adult heart transplant patients (N=11) and 18±5% in healthy volunteers (N=16).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:823b11cb-d873-4017-a861-d22d2c5a8a49 (opens source in a new tab)
Tacrolimus label
Version not recorded · Effective date not recorded
The absolute bioavailability of tacrolimus was 17±10% in adult kidney transplant patients (N=26), 22±6% in adult liver transplant patients (N=17), 23±9% in adult heart transplant patients (N=11) and 18±5% in healthy volunteers (N=16).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:34ec4989-6933-4237-ae1e-50a0cb90a2fe (opens source in a new tab)
Tacrolimus label
Version not recorded · Effective date not recorded
The absolute bioavailability of tacrolimus was 17 ± 10% in adult kidney transplant patients (N = 26), 22 ± 6% in adult liver transplant patients (N = 17), 23 ± 9% in adult heart transplant patients (N = 11) and 18 ± 5% in healthy volunteers (N = 16).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:4b310c6b-e035-4e44-9573-4001d58b2ad5 (opens source in a new tab)
Tacrolimus label
Version not recorded · Effective date not recorded
The absolute bioavailability of tacrolimus was 17 ± 10% in adult kidney transplant patients (N = 26), 22 ± 6% in adult liver transplant patients (N = 17), 23 ± 9% in adult heart transplant patients (N = 11) and 18 ± 5% in healthy volunteers (N = 16).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:0addf3f5-9bd5-4ef3-8c7f-52be20c16cf9 (opens source in a new tab)
Tacrolimus label
Version not recorded · Effective date not recorded
The absolute bioavailability of tacrolimus was 17±10% in adult kidney transplant patients (N=26), 22±6% in adult liver transplant patients (N=17), 23±9% in adult heart transplant patients (N=11) and 18±5% in healthy volunteers (N=16).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:393cd10e-133c-4d6b-b024-270eb82edbb3 (opens source in a new tab)
Tacrolimus label
Version not recorded · Effective date not recorded
The absolute bioavailability of tacrolimus was 17 ± 10% in adult kidney transplant patients (N = 26), 22 ± 6% in adult liver transplant patients (N = 17), 23 ± 9% in adult heart transplant patients (N = 11) and 18 ± 5% in healthy volunteers (N = 16).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:ca08d4aa-3de2-4a9d-9554-6288e5d36f29 (opens source in a new tab)
Tacrolimus label
Version not recorded · Effective date not recorded
The absolute bioavailability of Tacrolimus was 17±10% in adult kidney transplant patients (N=26), 22±6% in adult liver transplant patients (N=17), 23±9% in adult heart transplant patients (N=11) and 18±5% in healthy volunteers (N=16).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:54fcc518-21d9-44a8-9e2c-87ebc2b3e2e6 (opens source in a new tab)
Tacrolimus label
Version not recorded · Effective date not recorded
The absolute bioavailability of tacrolimus was 17 ± 10% in adult kidney transplant patients (N = 26), 22 ± 6% in adult liver transplant patients (N = 17), 23 ± 9% in adult heart transplant patients (N = 11) and 18 ± 5% in healthy volunteers (N = 16).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:46ac55cf-d85e-4c34-bb33-f49e078c4a03 (opens source in a new tab)
Tacrolimus label
Version not recorded · Effective date not recorded
The absolute bioavailability of tacrolimus was 17±10% in adult kidney transplant patients (N=26), 22±6% in adult liver transplant patients (N=17), 23±9% in adult heart transplant patients (N=11) and 18±5% in healthy volunteers (N=16).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:0a557ca9-b1a1-cf8f-a317-e4d8d4d6e60f (opens source in a new tab)
Tacrolimus label
Version not recorded · Effective date not recorded
The absolute bioavailability of tacrolimus was 17 ± 10% in adult kidney transplant patients (N = 26), 22 ± 6% in adult liver transplant patients (N = 17), 23 ± 9% in adult heart transplant patients (N = 11) and 18 ± 5% in healthy volunteers (N = 16).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:a2e55495-10cc-4f6e-b866-1e7d6e45888b (opens source in a new tab)
Tacrolimus label
Version not recorded · Effective date not recorded
The absolute bioavailability of tacrolimus was 17 ± 10% in adult kidney transplant patients (N = 26), 22 ± 6% in adult liver transplant patients (N = 17), 23 ± 9% in adult heart transplant patients (N = 11) and 18 ± 5% in healthy volunteers (N = 16).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:213f6047-f897-48a7-b78a-45d7124f2f16 (opens source in a new tab)
Tacrolimus label
Version not recorded · Effective date not recorded
The absolute bioavailability of tacrolimus was 17 ± 10% in adult kidney transplant patients (N = 26), 22 ± 6% in adult liver transplant patients (N = 17), 23 ± 9% in adult heart transplant patients (N = 11) and 18 ± 5% in healthy volunteers (N = 16).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:651bd506-96b0-43e5-a4dd-db03bf9154c9 (opens source in a new tab)
Tacrolimus label
Version not recorded · Effective date not recorded
The absolute bioavailability of tacrolimus was 17 ± 10% in adult kidney transplant patients (N = 26), 22 ± 6% in adult liver transplant patients (N = 17), 23 ± 9% in adult heart transplant patients (N = 11) and 18 ± 5% in healthy volunteers (N = 16).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:e898ee90-faae-42a8-b652-be1c8730d856 (opens source in a new tab)
Tacrolimus label
Version not recorded · Effective date not recorded
The absolute bioavailability of tacrolimus was 17 ± 10% in adult kidney transplant patients (N = 26), 22 ± 6% in adult liver transplant patients (N = 17), 23 ± 9% in adult heart transplant patients (N = 11) and 18 ± 5% in healthy volunteers (N = 16).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:976f1b69-dd96-4815-b11b-839ce1c45633 (opens source in a new tab)
Tacrolimus label
Version not recorded · Effective date not recorded
The absolute bioavailability of tacrolimus was 17±10% in adult kidney transplant patients (N=26), 22±6% in adult liver transplant patients (N=17), 23±9% in adult heart transplant patients (N=11) and 18±5% in healthy volunteers (N=16).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:3dc347e3-9bfd-4910-adb5-24e979208345 (opens source in a new tab)
Tacrolimus label
Version not recorded · Effective date not recorded
The absolute bioavailability of tacrolimus was 17±10% in adult kidney transplant patients (N=26), 22±6% in adult liver transplant patients (N=17), 23±9% in adult heart transplant patients (N=11) and 18±5% in healthy volunteers (N=16).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:6b89e8a4-9f11-42e3-8e79-fe617e7c461f (opens source in a new tab)
Tacrolimus label
Version not recorded · Effective date not recorded
The absolute bioavailability of tacrolimus was 17±10% in adult kidney transplant patients (N=26), 22±6% in adult liver transplant patients (N=17), 23±9% in adult heart transplant patients (N=11) and 18±5% in healthy volunteers (N=16).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:20d1c12a-bf4b-4467-93a0-ee8b892abea9 (opens source in a new tab)
Tacrolimus label
Version not recorded · Effective date not recorded
The absolute bioavailability of tacrolimus was 17±10% in adult kidney transplant patients (N=26), 22±6% in adult liver transplant patients (N=17), 23±9% in adult heart transplant patients (N=11) and 18±5% in healthy volunteers (N=16).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:4caa20af-45a8-4365-9f06-1568afae61b1 (opens source in a new tab)
Tacrolimus label
Version not recorded · Effective date not recorded
The absolute bioavailability of tacrolimus was 17 ± 10% in adult kidney transplant patients (N = 26), 22 ± 6% in adult liver transplant patients (N = 17), 23 ± 9% in adult heart transplant patients (N = 11) and 18 ± 5% in healthy volunteers (N = 16).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:23b7b4d7-1431-e9f2-43ba-eabd169dc2dd (opens source in a new tab)
Tacrolimus label
Version not recorded · Effective date not recorded
The absolute bioavailability of tacrolimus was 17±10% in adult kidney transplant patients (N=26), 22±6% in adult liver transplant patients (N=17), 23±9% in adult heart transplant patients (N=11) and 18±5% in healthy volunteers (N=16).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:9d502961-e9c0-4611-92bf-ce742a7b962c (opens source in a new tab)
Tacrolimus label
Version not recorded · Effective date not recorded
The absolute bioavailability of tacrolimus was 17 ± 10% in adult kidney transplant patients (N = 26), 22 ± 6% in adult liver transplant patients (N = 17), 23 ± 9% in adult heart transplant patients (N = 11) and 18 ± 5% in healthy volunteers (N = 16).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:875f4962-557e-4e12-ad7b-cb5fb6f2a65f (opens source in a new tab)
Tacrolimus label
Version not recorded · Effective date not recorded
The absolute bioavailability of tacrolimus was 17 ± 10% in adult kidney transplant patients (N = 26), 22 ± 6% in adult liver transplant patients (N = 17), 23 ± 9% in adult heart transplant patients (N = 11) and 18 ± 5% in healthy volunteers (N = 16).
12 ± 4.5%
- Numeric value
- 12
- Unit
- %
- Source records
- 1
Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.
Show all 1 source records
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:4eb1b6bd-beec-4dd5-9a48-c93a9fe918b3 (opens source in a new tab)
Tacrolimus label
Version not recorded · Effective date not recorded
The mean (± SD) absolute oral bioavailability (F) in African-Americans (12 ± 4.5%) and Latino-Americans (14 ± 7.4%) was lower than in Caucasians (19 ± 5.8%).
50%
- Numeric value
- 50
- Unit
- %
- Source records
- 1
Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.
Show all 1 source records
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:de2315b0-6344-43ac-9aea-3e3b68d828e7 (opens source in a new tab)
Tacrolimus label
Version not recorded · Effective date not recorded
In healthy subjects, the oral bioavailability of ENVARSUS XR was approximately 50% higher as compared with both tacrolimus immediate-release and extended-release capsule formulations at steady state.
Projected row 1442
- Medicine slug
- tacrolimus
- Compared field
- halfLife
- Comparison state
- insufficient_context
- Reason codes
- STRUCTURED_CONTEXT_MISSING
- Documents examined
- 44
- Source count
- 44
- Agreement rate
- 0.954545
- Recorded readings
48.1±15.9 hours
- Numeric value
- 48.1
- Unit
- hours
- Source records
- 42
Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.
Show all 42 source records
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:61dee012-43af-0e9a-3843-9b9b91e022c4 (opens source in a new tab)
Tacrolimus label
Version not recorded · Effective date not recorded
Fecal elimination accounted for 92.4±1% and the elimination half-life based on radioactivity was 48.1±15.9 hours whereas it was 43.5±11.6 hours based on tacrolimus concentrations.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:98e0584d-16d2-442b-86ce-e5e65239db0c (opens source in a new tab)
Tacrolimus label
Version not recorded · Effective date not recorded
Fecal elimination accounted for 92.4±1% and the elimination half-life based on radioactivity was 48.1±15.9 hours whereas it was 43.5±11.6 hours based on tacrolimus concentrations.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:759cf905-7406-4d1b-a1a8-10068cb11f04 (opens source in a new tab)
Tacrolimus label
Version not recorded · Effective date not recorded
Fecal elimination accounted for 92.4 ± 1.0% and the elimination half-life based on radioactivity was 48.1 ± 15.9 hours whereas it was 43.5 ± 11.6 hours based on tacrolimus concentrations.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:ed7d1495-3585-409d-94f1-b3d2469d222c (opens source in a new tab)
Tacrolimus label
Version not recorded · Effective date not recorded
Fecal elimination accounted for 92.4 ± 1.0% and the elimination half-life based on radioactivity was 48.1 ± 15.9 hours whereas it was 43.5 ± 11.6 hours based on tacrolimus concentrations.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:7f667de1-9dfa-4bd6-8ba0-15ee2d78873b (opens source in a new tab)
Tacrolimus label
Version not recorded · Effective date not recorded
Fecal elimination accounted for 92.4 ± 1.0% and the elimination half-life based on radioactivity was 48.1 ± 15.9 hours whereas it was 43.5 ± 11.6 hours based on tacrolimus concentrations.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:10ceb3bc-11cc-13e4-e063-6394a90acce4 (opens source in a new tab)
Tacrolimus label
Version not recorded · Effective date not recorded
Fecal elimination accounted for 92.4±1% and the elimination half-life based on radioactivity was 48.1±15.9 hours whereas it was 43.5±11.6 hours based on tacrolimus concentrations.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:93d03943-0655-44f6-b494-57bd1e336a34 (opens source in a new tab)
Tacrolimus label
Version not recorded · Effective date not recorded
Fecal elimination accounted for 92.4±1% and the elimination half-life based on radioactivity was 48.1±15.9 hours whereas it was 43.5±11.6 hours based on tacrolimus concentrations.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f21115e2-1d02-4bce-9c13-bf593a52a12f (opens source in a new tab)
Tacrolimus label
Version not recorded · Effective date not recorded
Fecal elimination accounted for 92.4±1% and the elimination half-life based on radioactivity was 48.1±15.9 hours whereas it was 43.5±11.6 hours based on tacrolimus concentrations.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:bd447ffa-9196-4c3c-accf-5adf29b84665 (opens source in a new tab)
Tacrolimus label
Version not recorded · Effective date not recorded
Fecal elimination accounted for 92.4 ± 1.0% and the elimination half-life based on radioactivity was 48.1 ± 15.9 hours whereas it was 43.5 ± 11.6 hours based on tacrolimus concentrations.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:5f742224-618e-4f4c-bdec-7693be99c697 (opens source in a new tab)
Tacrolimus label
Version not recorded · Effective date not recorded
Fecal elimination accounted for 92.4 ± 1.0% and the elimination half-life based on radioactivity was 48.1 ± 15.9 hours whereas it was 43.5 ± 11.6 hours based on tacrolimus concentrations.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:3519febc-c9df-4559-b07a-92f8b0c7e770 (opens source in a new tab)
Tacrolimus label
Version not recorded · Effective date not recorded
Fecal elimination accounted for 92.4 ± 1% and the elimination half-life based on radioactivity was 48.1 ± 15.9 hours whereas it was 43.5 ± 11.6 hours based on tacrolimus concentrations.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:bd9fea26-0236-d437-c7df-4b7636210875 (opens source in a new tab)
Tacrolimus label
Version not recorded · Effective date not recorded
Fecal elimination accounted for 92.4 ± 1.0% and the elimination half-life based on radioactivity was 48.1 ± 15.9 hours whereas it was 43.5 ± 11.6 hours based on tacrolimus concentrations.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:1bf44a84-14fd-4f80-ad8a-99b1431d631f (opens source in a new tab)
Tacrolimus label
Version not recorded · Effective date not recorded
Fecal elimination accounted for 92.4 ± 1.0% and the elimination half-life based on radioactivity was 48.1 ± 15.9 hours whereas it was 43.5 ± 11.6 hours based on tacrolimus concentrations.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:27154d3a-eec5-4000-a4ff-bfbfe27eb806 (opens source in a new tab)
Tacrolimus label
Version not recorded · Effective date not recorded
Fecal elimination accounted for 92.4±1% and the elimination half-life based on radioactivity was 48.1±15.9 hours whereas it was 43.5±11.6 hours based on tacrolimus concentrations.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:80e6817a-9b1e-4f0f-e053-2a91aa0a3d15 (opens source in a new tab)
Tacrolimus label
Version not recorded · Effective date not recorded
Fecal elimination accounted for 92.4 ± 1.0% and the elimination half-life based on radioactivity was 48.1 ± 15.9 hours whereas it was 43.5 ± 11.6 hours based on tacrolimus concentrations.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:450c3e32-6d91-4508-b064-49b293e86cec (opens source in a new tab)
Tacrolimus label
Version not recorded · Effective date not recorded
Fecal elimination accounted for 92.4 ± 1.0% and the elimination half-life based on radioactivity was 48.1 ± 15.9 hours whereas it was 43.5 ± 11.6 hours based on tacrolimus concentrations.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:45af3eda-caaa-4478-9372-95aa65adc9b3 (opens source in a new tab)
Tacrolimus label
Version not recorded · Effective date not recorded
Fecal elimination accounted for 92.4 ± 1.0% and the elimination half-life based on radioactivity was 48.1 ± 15.9 hours whereas it was 43.5 ± 11.6 hours based on tacrolimus concentrations.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:55467f4b-8437-43a3-b6d9-1bc2a13b4c11 (opens source in a new tab)
Tacrolimus label
Version not recorded · Effective date not recorded
Fecal elimination accounted for 92.4±1.0% and the elimination half-life based on radioactivity was 48.1±15.9 hours whereas it was 43.5±11.6 hours based on tacrolimus concentrations.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:3e8bc65e-8048-4073-8e45-570330603000 (opens source in a new tab)
Tacrolimus label
Version not recorded · Effective date not recorded
Fecal elimination accounted for 92.4±1.0% and the elimination half-life based on radioactivity was 48.1±15.9 hours whereas it was 43.5±11.6 hours based on tacrolimus concentrations.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:823b11cb-d873-4017-a861-d22d2c5a8a49 (opens source in a new tab)
Tacrolimus label
Version not recorded · Effective date not recorded
Fecal elimination accounted for 92.4±1.0% and the elimination half-life based on radioactivity was 48.1±15.9 hours whereas it was 43.5±11.6 hours based on tacrolimus concentrations.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:34ec4989-6933-4237-ae1e-50a0cb90a2fe (opens source in a new tab)
Tacrolimus label
Version not recorded · Effective date not recorded
Fecal elimination accounted for 92.4 ± 1.0% and the elimination half-life based on radioactivity was 48.1 ± 15.9 hours whereas it was 43.5 ± 11.6 hours based on tacrolimus concentrations.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:4b310c6b-e035-4e44-9573-4001d58b2ad5 (opens source in a new tab)
Tacrolimus label
Version not recorded · Effective date not recorded
Fecal elimination accounted for 92.4 ± 1% and the elimination half-life based on radioactivity was 48.1 ± 15.9 hours whereas it was 43.5 ± 11.6 hours based on tacrolimus concentrations.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:0addf3f5-9bd5-4ef3-8c7f-52be20c16cf9 (opens source in a new tab)
Tacrolimus label
Version not recorded · Effective date not recorded
Fecal elimination accounted for 92.4±1% and the elimination half-life based on radioactivity was 48.1±15.9 hours whereas it was 43.5±11.6 hours based on tacrolimus concentrations.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:393cd10e-133c-4d6b-b024-270eb82edbb3 (opens source in a new tab)
Tacrolimus label
Version not recorded · Effective date not recorded
Fecal elimination accounted for 92.4 ± 1.0% and the elimination half-life based on radioactivity was 48.1 ± 15.9 hours whereas it was 43.5 ± 11.6 hours based on tacrolimus concentrations.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:ca08d4aa-3de2-4a9d-9554-6288e5d36f29 (opens source in a new tab)
Tacrolimus label
Version not recorded · Effective date not recorded
Fecal elimination accounted for 92.4±1.0% and the elimination half-life based on radioactivity was 48.1±15.9 hours whereas it was 43.5±11.6 hours based on Tacrolimus concentrations.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:54fcc518-21d9-44a8-9e2c-87ebc2b3e2e6 (opens source in a new tab)
Tacrolimus label
Version not recorded · Effective date not recorded
Fecal elimination accounted for 92.4 ± 1.0% and the elimination half-life based on radioactivity was 48.1 ± 15.9 hours whereas it was 43.5 ± 11.6 hours based on tacrolimus concentrations.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:46ac55cf-d85e-4c34-bb33-f49e078c4a03 (opens source in a new tab)
Tacrolimus label
Version not recorded · Effective date not recorded
Fecal elimination accounted for 92.4±1% and the elimination half-life based on radioactivity was 48.1±15.9 hours whereas it was 43.5±11.6 hours based on tacrolimus concentrations.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:0a557ca9-b1a1-cf8f-a317-e4d8d4d6e60f (opens source in a new tab)
Tacrolimus label
Version not recorded · Effective date not recorded
Fecal elimination accounted for 92.4 ± 1.0% and the elimination half-life based on radioactivity was 48.1 ± 15.9 hours whereas it was 43.5 ± 11.6 hours based on tacrolimus concentrations.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:a2e55495-10cc-4f6e-b866-1e7d6e45888b (opens source in a new tab)
Tacrolimus label
Version not recorded · Effective date not recorded
Fecal elimination accounted for 92.4 ± 1.0% and the elimination half-life based on radioactivity was 48.1 ± 15.9 hours whereas it was 43.5 ± 11.6 hours based on tacrolimus concentrations.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:213f6047-f897-48a7-b78a-45d7124f2f16 (opens source in a new tab)
Tacrolimus label
Version not recorded · Effective date not recorded
Fecal elimination accounted for 92.4 ± 1.0% and the elimination half-life based on radioactivity was 48.1 ± 15.9 hours whereas it was 43.5 ± 11.6 hours based on tacrolimus concentrations.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:651bd506-96b0-43e5-a4dd-db03bf9154c9 (opens source in a new tab)
Tacrolimus label
Version not recorded · Effective date not recorded
Fecal elimination accounted for 92.4 ± 1.0% and the elimination half-life based on radioactivity was 48.1 ± 15.9 hours whereas it was 43.5 ± 11.6 hours based on tacrolimus concentrations.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:e898ee90-faae-42a8-b652-be1c8730d856 (opens source in a new tab)
Tacrolimus label
Version not recorded · Effective date not recorded
Fecal elimination accounted for 92.4 ± 1.0% and the elimination half-life based on radioactivity was 48.1 ± 15.9 hours whereas it was 43.5 ± 11.6 hours based on tacrolimus concentrations.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:6b601eaf-4f3a-4a8b-8cd8-1000defa9822 (opens source in a new tab)
Tacrolimus label
Version not recorded · Effective date not recorded
Fecal elimination accounted for 92.4 ± 1.0% and the elimination half-life based on radioactivity was 48.1 ± 15.9 hours whereas it was 43.5 ± 11.6 hours based on tacrolimus concentrations.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:976f1b69-dd96-4815-b11b-839ce1c45633 (opens source in a new tab)
Tacrolimus label
Version not recorded · Effective date not recorded
Fecal elimination accounted for 92.4±1% and the elimination half-life based on radioactivity was 48.1±15.9 hours whereas it was 43.5±11.6 hours based on tacrolimus concentrations.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:3dc347e3-9bfd-4910-adb5-24e979208345 (opens source in a new tab)
Tacrolimus label
Version not recorded · Effective date not recorded
Fecal elimination accounted for 92.4±1% and the elimination half-life based on radioactivity was 48.1±15.9 hours whereas it was 43.5±11.6 hours based on tacrolimus concentrations.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:c2d2e3a1-f346-4245-b445-6dd44e371180 (opens source in a new tab)
Tacrolimus label
Version not recorded · Effective date not recorded
Fecal elimination accounted for 92.4 ± 1% and the elimination half-life based on radioactivity was 48.1 ± 15.9 hours whereas it was 43.5 ± 11.6 hours based on tacrolimus concentrations.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:6b89e8a4-9f11-42e3-8e79-fe617e7c461f (opens source in a new tab)
Tacrolimus label
Version not recorded · Effective date not recorded
Fecal elimination accounted for 92.4±1.0% and the elimination half-life based on radioactivity was 48.1±15.9 hours whereas it was 43.5±11.6 hours based on tacrolimus concentrations.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:20d1c12a-bf4b-4467-93a0-ee8b892abea9 (opens source in a new tab)
Tacrolimus label
Version not recorded · Effective date not recorded
Fecal elimination accounted for 92.4±1% and the elimination half-life based on radioactivity was 48.1±15.9 hours whereas it was 43.5±11.6 hours based on tacrolimus concentrations.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:4caa20af-45a8-4365-9f06-1568afae61b1 (opens source in a new tab)
Tacrolimus label
Version not recorded · Effective date not recorded
Fecal elimination accounted for 92.4 ± 1% and the elimination half-life based on radioactivity was 48.1 ± 15.9 hours whereas it was 43.5 ± 11.6 hours based on tacrolimus concentrations.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:23b7b4d7-1431-e9f2-43ba-eabd169dc2dd (opens source in a new tab)
Tacrolimus label
Version not recorded · Effective date not recorded
Fecal elimination accounted for 92.4±1% and the elimination half-life based on radioactivity was 48.1±15.9 hours whereas it was 43.5±11.6 hours based on tacrolimus concentrations.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:9d502961-e9c0-4611-92bf-ce742a7b962c (opens source in a new tab)
Tacrolimus label
Version not recorded · Effective date not recorded
Fecal elimination accounted for 92.4 ± 1.0% and the elimination half-life based on radioactivity was 48.1 ± 15.9 hours whereas it was 43.5 ± 11.6 hours based on tacrolimus concentrations.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:875f4962-557e-4e12-ad7b-cb5fb6f2a65f (opens source in a new tab)
Tacrolimus label
Version not recorded · Effective date not recorded
Fecal elimination accounted for 92.4 ± 1% and the elimination half-life based on radioactivity was 48.1 ± 15.9 hours whereas it was 43.5 ± 11.6 hours based on tacrolimus concentrations.
31.9 ± 10.5 hours
- Numeric value
- 31.9
- Unit
- hours
- Source records
- 1
Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.
Show all 1 source records
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:de2315b0-6344-43ac-9aea-3e3b68d828e7 (opens source in a new tab)
Tacrolimus label
Version not recorded · Effective date not recorded
The elimination half-life based on radioactivity was 31.9 ± 10.5 hours, whereas it was 48.4 ± 12.3 hours based on tacrolimus concentrations.
36 hours
- Numeric value
- 36
- Unit
- hours
- Source records
- 1
Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.
Show all 1 source records
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:4eb1b6bd-beec-4dd5-9a48-c93a9fe918b3 (opens source in a new tab)
Tacrolimus label
Version not recorded · Effective date not recorded
Food delayed the median T max from 2 hours in the fasted state to 4 hours in the fed state; however, the terminal half-life remained 36 hours regardless of dosing conditions.
Projected row 1443
- Medicine slug
- tacrolimus
- Compared field
- proteinBinding
- Comparison state
- agree
- Reason codes
- COMPATIBLE_VALUES_OVERLAP
- Documents examined
- 44
- Source count
- 44
- Agreement rate
- 1
- Recorded readings
99%
- Numeric value
- 99
- Unit
- %
- Source records
- 44
Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.
Show all 44 source records
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:61dee012-43af-0e9a-3843-9b9b91e022c4 (opens source in a new tab)
Tacrolimus label
Version not recorded · Effective date not recorded
Distribution The plasma protein binding of tacrolimus is approximately 99% and is independent of concentration over a range of 5 to 50 ng/mL.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:98e0584d-16d2-442b-86ce-e5e65239db0c (opens source in a new tab)
Tacrolimus label
Version not recorded · Effective date not recorded
Distribution The plasma protein binding of tacrolimus is approximately 99% and is independent of concentration over a range of 5 to 50 ng/mL.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:759cf905-7406-4d1b-a1a8-10068cb11f04 (opens source in a new tab)
Tacrolimus label
Version not recorded · Effective date not recorded
Distribution The plasma protein binding of tacrolimus is approximately 99% and is independent of concentration over a range of 5-50 ng/mL.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:ed7d1495-3585-409d-94f1-b3d2469d222c (opens source in a new tab)
Tacrolimus label
Version not recorded · Effective date not recorded
Distribution The plasma protein binding of tacrolimus is approximately 99% and is independent of concentration over a range of 5-50 ng/mL.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:7f667de1-9dfa-4bd6-8ba0-15ee2d78873b (opens source in a new tab)
Tacrolimus label
Version not recorded · Effective date not recorded
Distribution The plasma protein binding of tacrolimus is approximately 99% and is independent of concentration over a range of 5‑50 ng/mL.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:10ceb3bc-11cc-13e4-e063-6394a90acce4 (opens source in a new tab)
Tacrolimus label
Version not recorded · Effective date not recorded
Distribution The plasma protein binding of tacrolimus is approximately 99% and is independent of concentration over a range of 5 to 50 ng/mL.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:93d03943-0655-44f6-b494-57bd1e336a34 (opens source in a new tab)
Tacrolimus label
Version not recorded · Effective date not recorded
Distribution The plasma protein binding of tacrolimus is approximately 99% and is independent of concentration over a range of 5 to 50 ng/mL.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f21115e2-1d02-4bce-9c13-bf593a52a12f (opens source in a new tab)
Tacrolimus label
Version not recorded · Effective date not recorded
Distribution The plasma protein binding of tacrolimus is approximately 99% and is independent of concentration over a range of 5 to 50 ng/mL.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:bd447ffa-9196-4c3c-accf-5adf29b84665 (opens source in a new tab)
Tacrolimus label
Version not recorded · Effective date not recorded
Distribution The plasma protein binding of tacrolimus is approximately 99% and is independent of concentration over a range of 5 to 50 ng/mL.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:5f742224-618e-4f4c-bdec-7693be99c697 (opens source in a new tab)
Tacrolimus label
Version not recorded · Effective date not recorded
Distribution The plasma protein binding of tacrolimus is approximately 99% and is independent of concentration over a range of 5-50 ng/mL.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:3519febc-c9df-4559-b07a-92f8b0c7e770 (opens source in a new tab)
Tacrolimus label
Version not recorded · Effective date not recorded
Distribution The plasma protein binding of tacrolimus is approximately 99% and is independent of concentration over a range of 5 to 50 ng/mL.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:bd9fea26-0236-d437-c7df-4b7636210875 (opens source in a new tab)
Tacrolimus label
Version not recorded · Effective date not recorded
Distribution The plasma protein binding of tacrolimus is approximately 99% and is independent of concentration over a range of 5-50 ng/mL.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:1bf44a84-14fd-4f80-ad8a-99b1431d631f (opens source in a new tab)
Tacrolimus label
Version not recorded · Effective date not recorded
Distribution The plasma protein binding of tacrolimus is approximately 99% and is independent of concentration over a range of 5-50 ng/mL.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:27154d3a-eec5-4000-a4ff-bfbfe27eb806 (opens source in a new tab)
Tacrolimus label
Version not recorded · Effective date not recorded
Distribution The plasma protein binding of tacrolimus is approximately 99% and is independent of concentration over a range of 5 to 50 ng/mL.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:80e6817a-9b1e-4f0f-e053-2a91aa0a3d15 (opens source in a new tab)
Tacrolimus label
Version not recorded · Effective date not recorded
Distribution The plasma protein binding of tacrolimus is approximately 99% and is independent of concentration over a range of 5 to 50 ng/mL.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:450c3e32-6d91-4508-b064-49b293e86cec (opens source in a new tab)
Tacrolimus label
Version not recorded · Effective date not recorded
Distribution The plasma protein binding of tacrolimus is approximately 99% and is independent of concentration over a range of 5-50 ng/mL.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:45af3eda-caaa-4478-9372-95aa65adc9b3 (opens source in a new tab)
Tacrolimus label
Version not recorded · Effective date not recorded
Distribution The plasma protein binding of tacrolimus is approximately 99% and is independent of concentration over a range of 5-50 ng/mL.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:55467f4b-8437-43a3-b6d9-1bc2a13b4c11 (opens source in a new tab)
Tacrolimus label
Version not recorded · Effective date not recorded
Distribution The plasma protein binding of tacrolimus is approximately 99% and is independent of concentration over a range of 5 to 50 ng/mL.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:3e8bc65e-8048-4073-8e45-570330603000 (opens source in a new tab)
Tacrolimus label
Version not recorded · Effective date not recorded
Distribution The plasma protein binding of tacrolimus is approximately 99% and is independent of concentration over a range of 5-50 ng/mL.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:4eb1b6bd-beec-4dd5-9a48-c93a9fe918b3 (opens source in a new tab)
Tacrolimus label
Version not recorded · Effective date not recorded
Distribution The plasma protein binding of tacrolimus is approximately 99% and is independent of concentration over a range of 5 ng/mL to 50 ng/mL.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:823b11cb-d873-4017-a861-d22d2c5a8a49 (opens source in a new tab)
Tacrolimus label
Version not recorded · Effective date not recorded
Distribution The plasma protein binding of tacrolimus is approximately 99% and is independent of concentration over a range of 5-50 ng/mL.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:34ec4989-6933-4237-ae1e-50a0cb90a2fe (opens source in a new tab)
Tacrolimus label
Version not recorded · Effective date not recorded
Distribution The plasma protein binding of tacrolimus is approximately 99% and is independent of concentration over a range of 5-50 ng/mL.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:4b310c6b-e035-4e44-9573-4001d58b2ad5 (opens source in a new tab)
Tacrolimus label
Version not recorded · Effective date not recorded
Distribution The plasma protein binding of tacrolimus is approximately 99% and is independent of concentration over a range of 5 to 50 ng/mL.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:0addf3f5-9bd5-4ef3-8c7f-52be20c16cf9 (opens source in a new tab)
Tacrolimus label
Version not recorded · Effective date not recorded
Distribution The plasma protein binding of tacrolimus is approximately 99% and is independent of concentration over a range of 5 to 50 ng/mL.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:393cd10e-133c-4d6b-b024-270eb82edbb3 (opens source in a new tab)
Tacrolimus label
Version not recorded · Effective date not recorded
Distribution The plasma protein binding of tacrolimus is approximately 99% and is independent of concentration over a range of 5-50 ng/mL.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:ca08d4aa-3de2-4a9d-9554-6288e5d36f29 (opens source in a new tab)
Tacrolimus label
Version not recorded · Effective date not recorded
Distribution The plasma protein binding of Tacrolimus is approximately 99% and is independent of concentration over a range of 5-50 ng/mL.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:54fcc518-21d9-44a8-9e2c-87ebc2b3e2e6 (opens source in a new tab)
Tacrolimus label
Version not recorded · Effective date not recorded
Distribution The plasma protein binding of tacrolimus is approximately 99% and is independent of concentration over a range of 5 to 50 ng/mL.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:46ac55cf-d85e-4c34-bb33-f49e078c4a03 (opens source in a new tab)
Tacrolimus label
Version not recorded · Effective date not recorded
Distribution The plasma protein binding of tacrolimus is approximately 99% and is independent of concentration over a range of 5 to 50 ng/mL.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:0a557ca9-b1a1-cf8f-a317-e4d8d4d6e60f (opens source in a new tab)
Tacrolimus label
Version not recorded · Effective date not recorded
Distribution The plasma protein binding of tacrolimus is approximately 99% and is independent of concentration over a range of 5 to 50 ng/mL.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:a2e55495-10cc-4f6e-b866-1e7d6e45888b (opens source in a new tab)
Tacrolimus label
Version not recorded · Effective date not recorded
Distribution The plasma protein binding of tacrolimus is approximately 99% and is independent of concentration over a range of 5 to 50 ng/mL.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:213f6047-f897-48a7-b78a-45d7124f2f16 (opens source in a new tab)
Tacrolimus label
Version not recorded · Effective date not recorded
Distribution The plasma protein binding of tacrolimus is approximately 99% and is independent of concentration over a range of 5-50 ng/mL.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:651bd506-96b0-43e5-a4dd-db03bf9154c9 (opens source in a new tab)
Tacrolimus label
Version not recorded · Effective date not recorded
Distribution The plasma protein binding of tacrolimus is approximately 99% and is independent of concentration over a range of 5-50 ng/mL.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:e898ee90-faae-42a8-b652-be1c8730d856 (opens source in a new tab)
Tacrolimus label
Version not recorded · Effective date not recorded
Distribution The plasma protein binding of tacrolimus is approximately 99% and is independent of concentration over a range of 5 to 50 ng/mL.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:6b601eaf-4f3a-4a8b-8cd8-1000defa9822 (opens source in a new tab)
Tacrolimus label
Version not recorded · Effective date not recorded
Distribution The plasma protein binding of tacrolimus is approximately 99% and is independent of concentration over a range of 5-50 ng/mL.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:976f1b69-dd96-4815-b11b-839ce1c45633 (opens source in a new tab)
Tacrolimus label
Version not recorded · Effective date not recorded
Distribution The plasma protein binding of tacrolimus is approximately 99% and is independent of concentration over a range of 5 to 50 ng/mL.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:de2315b0-6344-43ac-9aea-3e3b68d828e7 (opens source in a new tab)
Tacrolimus label
Version not recorded · Effective date not recorded
Distribution The plasma protein binding of tacrolimus is approximately 99% and is independent of concentration over a range of 5-50 ng/mL.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:3dc347e3-9bfd-4910-adb5-24e979208345 (opens source in a new tab)
Tacrolimus label
Version not recorded · Effective date not recorded
Distribution The plasma protein binding of tacrolimus is approximately 99% and is independent of concentration over a range of 5 to 50 ng/mL.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:c2d2e3a1-f346-4245-b445-6dd44e371180 (opens source in a new tab)
Tacrolimus label
Version not recorded · Effective date not recorded
Distribution The plasma protein binding of tacrolimus is approximately 99% and is independent of concentration over a range of 5 to 50 ng/mL.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:6b89e8a4-9f11-42e3-8e79-fe617e7c461f (opens source in a new tab)
Tacrolimus label
Version not recorded · Effective date not recorded
Distribution The plasma protein binding of tacrolimus is approximately 99% and is independent of concentration over a range of 5 ng/mL to 50 ng/mL.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:20d1c12a-bf4b-4467-93a0-ee8b892abea9 (opens source in a new tab)
Tacrolimus label
Version not recorded · Effective date not recorded
Distribution The plasma protein binding of tacrolimus is approximately 99% and is independent of concentration over a range of 5 to 50 ng/mL.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:4caa20af-45a8-4365-9f06-1568afae61b1 (opens source in a new tab)
Tacrolimus label
Version not recorded · Effective date not recorded
Distribution The plasma protein binding of tacrolimus is approximately 99% and is independent of concentration over a range of 5 to 50 ng/mL.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:23b7b4d7-1431-e9f2-43ba-eabd169dc2dd (opens source in a new tab)
Tacrolimus label
Version not recorded · Effective date not recorded
Distribution The plasma protein binding of tacrolimus is approximately 99% and is independent of concentration over a range of 5 to 50 ng/mL.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:9d502961-e9c0-4611-92bf-ce742a7b962c (opens source in a new tab)
Tacrolimus label
Version not recorded · Effective date not recorded
Distribution The plasma protein binding of tacrolimus is approximately 99% and is independent of concentration over a range of 5–50 nanogram/mL.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:875f4962-557e-4e12-ad7b-cb5fb6f2a65f (opens source in a new tab)
Tacrolimus label
Version not recorded · Effective date not recorded
Distribution The plasma protein binding of tacrolimus is approximately 99% and is independent of concentration over a range of 5 to 50 ng/mL.
Projected row 1444
- Medicine slug
- tadalafil
- Compared field
- halfLife
- Comparison state
- insufficient_context
- Reason codes
- STRUCTURED_CONTEXT_MISSING
- Documents examined
- 141
- Source count
- 141
- Agreement rate
- 0.886525
- Recorded readings
17.5 hours
- Numeric value
- 17.5
- Unit
- hours
- Source records
- 125
Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.
Show all 125 source records
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:36350106-98bc-41fc-bede-8be5e6f54a8a (opens source in a new tab)
Tadalafil label
Version not recorded · Effective date not recorded
Excretion — The mean oral clearance for tadalafil is 2.5 L/hr and the mean terminal half-life is 17.5 hours in healthy subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:a3190ceb-fb3f-45f7-a12d-4c333edaadc6 (opens source in a new tab)
Tadalafil label
Version not recorded · Effective date not recorded
Excretion - The mean oral clearance for tadalafil is 2.5 L/hr and the mean terminal half-life is 17.5 hours in healthy subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:594acc15-a5bc-43b5-9659-a864b2c46eea (opens source in a new tab)
Tadalafil label
Version not recorded · Effective date not recorded
Excretion - The mean oral clearance for tadalafil is 2.5 L/hr and the mean terminal half-life is 17.5 hours in healthy subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:31c05a53-7282-46d0-81bd-108defe6fb38 (opens source in a new tab)
Tadalafil label
Version not recorded · Effective date not recorded
Excretion — The mean oral clearance for tadalafil is 2.5 L/hr and the mean terminal half-life is 17.5 hours in healthy subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:a930511d-110e-4d2e-a4ca-df712f968b2d (opens source in a new tab)
Tadalafil label
Version not recorded · Effective date not recorded
Excretion —The mean oral clearance for tadalafil is 2.5 L/hr and the mean terminal half-life is 17.5 hours in healthy subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:0a9cf85a-c17d-6890-e063-6394a90a93e9 (opens source in a new tab)
Tadalafil label
Version not recorded · Effective date not recorded
Excretion — The mean oral clearance for tadalafil is 2.5 L/hr and the mean terminal half-life is 17.5 hours in healthy subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:716c586d-e524-4f3e-ab1d-7ef9184169d9 (opens source in a new tab)
Tadalafil label
Version not recorded · Effective date not recorded
Excretion — The mean oral clearance for tadalafil is 2.5 L/hr and the mean terminal half-life is 17.5 hours in healthy subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:09ad27a1-3908-4533-b84c-7a7fd3514101 (opens source in a new tab)
Tadalafil label
Version not recorded · Effective date not recorded
Excretion — The mean oral clearance for tadalafil is 2.5 L/hr and the mean terminal half-life is 17.5 hours in healthy subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:761dc0f8-2f65-4615-ab49-a4bcffd40ce9 (opens source in a new tab)
Tadalafil label
Version not recorded · Effective date not recorded
Excretion — The mean oral clearance for tadalafil is 2.5 L/hr and the mean terminal half-life is 17.5 hours in healthy subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:741102c1-8809-44d4-9098-3dc8c0604764 (opens source in a new tab)
Tadalafil label
Version not recorded · Effective date not recorded
Excretion - The mean oral clearance for tadalafil is 2.5 L/hr and the mean terminal half-life is 17.5 hours in healthy subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f317fe1e-d7c4-fb8b-e053-2a95a90a5445 (opens source in a new tab)
Tadalafil label
Version not recorded · Effective date not recorded
Excretion — The mean oral clearance for tadalafil is 2.5 L/hr and the mean terminal half-life is 17.5 hours in healthy subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:ad288e9d-020a-43a0-9c07-320c5c3bbc1e (opens source in a new tab)
Tadalafil label
Version not recorded · Effective date not recorded
Excretion — The mean oral clearance for tadalafil is 2.5 L/hr and the mean terminal half-life is 17.5 hours in healthy subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:eedf3ad9-7d40-496d-b1a9-6200010c18e1 (opens source in a new tab)
Tadalafil label
Version not recorded · Effective date not recorded
Excretion — The mean oral clearance for tadalafil is 2.5 L/hr and the mean terminal half-life is 17.5 hours in healthy subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:351e28ca-3ae6-e535-e063-6394a90a9fb7 (opens source in a new tab)
Tadalafil label
Version not recorded · Effective date not recorded
Excretion — The mean oral clearance for tadalafil is 2.5 L/hr and the mean terminal half-life is 17.5 hours in healthy subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f2e8821e-04c9-4812-8c9e-39340775cc6e (opens source in a new tab)
Tadalafil label
Version not recorded · Effective date not recorded
E xcr etion — The mean oral clearance for tadalafil is 2.5 L/hr and the mean terminal half-life is 17.5 hours in healthy subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f295f164-78fb-4224-b319-9f20b7a453b5 (opens source in a new tab)
Tadalafil label
Version not recorded · Effective date not recorded
Excretion — The mean oral clearance for tadalafil is 2.5 L/hr and the mean terminal half-life is 17.5 hours in healthy subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:aba646fe-70c2-1abb-e053-2995a90aa16d (opens source in a new tab)
Tadalafil label
Version not recorded · Effective date not recorded
Excretion — The mean oral clearance for tadalafil is 2.5 L/hr and the mean terminal half-life is 17.5 hours in healthy subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:6fd94914-0c9d-4268-8ed8-3c2690707a5d (opens source in a new tab)
Tadalafil label
Version not recorded · Effective date not recorded
Excretion - The mean oral clearance for tadalafil is 2.5 L/hr and the mean terminal half-life is 17.5 hours in healthy subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:cfe43ab8-8721-4db8-8810-f0072cf8f4d3 (opens source in a new tab)
Tadalafil label
Version not recorded · Effective date not recorded
Excretion The mean oral clearance for tadalafil is 2.5 L/hr and the mean terminal half-life is 17.5 hours in healthy subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:30ae58ed-5b56-4513-8eb3-eb4f89b78f9d (opens source in a new tab)
Tadalafil label
Version not recorded · Effective date not recorded
Excretion - The mean oral clearance for tadalafil is 2.5 L/hr and the mean terminal half-life is 17.5 hours in healthy subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:9f83ea2e-8ee8-ab6d-e053-2995a90a1e96 (opens source in a new tab)
Tadalafil label
Version not recorded · Effective date not recorded
Excretion — The mean oral clearance for tadalafil is 2.5 L/hr and the mean terminal half-life is 17.5 hours in healthy subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:a84c1eab-5934-4e5d-8bb2-0734d6adba6a (opens source in a new tab)
Tadalafil label
Version not recorded · Effective date not recorded
Excretion - The mean oral clearance for tadalafil is 2.5 L/hr and the mean terminal half-life is 17.5 hours in healthy subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:1580ab76-e229-4b8d-8c7b-82f39fecfebd (opens source in a new tab)
Tadalafil label
Version not recorded · Effective date not recorded
Excretion - The mean oral clearance for tadalafil is 2.5 L/hr and the mean terminal half-life is 17.5 hours in healthy subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f3092f5a-b976-91ab-e053-2995a90a9b50 (opens source in a new tab)
Tadalafil label
Version not recorded · Effective date not recorded
Excretion — The mean oral clearance for tadalafil is 2.5 L/hr and the mean terminal half-life is 17.5 hours in healthy subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:5ea24573-2d16-40d8-a46c-7b5fa8669e69 (opens source in a new tab)
Tadalafil label
Version not recorded · Effective date not recorded
Excretion — The mean oral clearance for tadalafil is 2.5 L/hr and the mean terminal half-life is 17.5 hours in healthy subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:c3409762-3b2b-1cfc-e053-2995a90ab91b (opens source in a new tab)
Tadalafil label
Version not recorded · Effective date not recorded
Excretion — The mean oral clearance for tadalafil is 2.5 L/hr and the mean terminal half-life is 17.5 hours in healthy subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:fee8c2be-ccfa-4c66-abed-5e232ec762ae (opens source in a new tab)
Tadalafil label
Version not recorded · Effective date not recorded
Excretion — The mean oral clearance for tadalafil is 2.5 L/hr and the mean terminal half-life is 17.5 hours in healthy subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:2c277890-3c5d-5fd5-e063-6394a90af15b (opens source in a new tab)
Tadalafil label
Version not recorded · Effective date not recorded
Excretion — The mean oral clearance for tadalafil is 2.5 L/hr and the mean terminal half-life is 17.5 hours in healthy subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:351de7c2-98bf-7c88-e063-6294a90ad811 (opens source in a new tab)
Tadalafil label
Version not recorded · Effective date not recorded
Excretion — The mean oral clearance for tadalafil is 2.5 L/hr and the mean terminal half-life is 17.5 hours in healthy subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:a3892605-4eb1-4d6e-a675-f7f7d4302f38 (opens source in a new tab)
Tadalafil label
Version not recorded · Effective date not recorded
Excretion — The mean oral clearance for tadalafil is 2.5 L/hr and the mean terminal half-life is 17.5 hours in healthy subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:6fa9d4fa-86c9-4791-b28b-78e8b9341cea (opens source in a new tab)
Tadalafil label
Version not recorded · Effective date not recorded
Excretion — The mean oral clearance for tadalafil is 2.5 L/hr and the mean terminal half-life is 17.5 hours in healthy subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:929e391e-b74b-4ccd-8690-16ffcece7a30 (opens source in a new tab)
Tadalafil label
Version not recorded · Effective date not recorded
Excretion — The mean oral clearance for tadalafil is 2.5 L/hr and the mean terminal half-life is 17.5 hours in healthy subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:cf35291b-b05b-1182-e053-2995a90a8dee (opens source in a new tab)
Tadalafil label
Version not recorded · Effective date not recorded
Excretion — The mean oral clearance for tadalafil is 2.5 L/hr and the mean terminal half-life is 17.5 hours in healthy subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:b1840f16-a7ea-44bd-b091-5268990aedb2 (opens source in a new tab)
Tadalafil label
Version not recorded · Effective date not recorded
Excretion — The mean oral clearance for tadalafil is 2.5 L/hr and the mean terminal half-life is 17.5 hours in healthy subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:abcb2cda-9b3f-45f6-ad5f-c2370b0dd114 (opens source in a new tab)
Tadalafil label
Version not recorded · Effective date not recorded
Excretion - The mean oral clearance for tadalafil is 2.5 L/hr and the mean terminal half-life is 17.5 hours in healthy subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:6c680b37-d515-4fc2-83e6-411f1017e18c (opens source in a new tab)
Tadalafil label
Version not recorded · Effective date not recorded
Excretion — The mean oral clearance for tadalafil is 2.5 L/hr and the mean terminal half-life is 17.5 hours in healthy subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:3ea7612b-b004-43ef-accc-34c8ec5146b8 (opens source in a new tab)
Tadalafil label
Version not recorded · Effective date not recorded
Excretion — The mean oral clearance for tadalafil is 2.5 L/hr and the mean terminal half-life is 17.5 hours in healthy subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:aa8d165b-0c7d-497a-b56a-7c62ebc0a5d2 (opens source in a new tab)
Tadalafil label
Version not recorded · Effective date not recorded
Excretion — The mean oral clearance for tadalafil is 2.5 L/hr and the mean terminal half-life is 17.5 hours in healthy subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:a10d464a-6ea7-4e5a-befa-71eceacc5039 (opens source in a new tab)
Tadalafil label
Version not recorded · Effective date not recorded
Excretion —The mean oral clearance for tadalafil is 2.5 L/hr and the mean terminal half-life is 17.5 hours in healthy subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:ca1d46e3-ad9b-48c7-bb7f-63ee678ccf7a (opens source in a new tab)
Tadalafil label
Version not recorded · Effective date not recorded
Excretion —The mean oral clearance for tadalafil is 2.5 L/hr and the mean terminal half-life is 17.5 hours in healthy subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:b539e862-d5d4-4989-a3dd-1eba66285d53 (opens source in a new tab)
Tadalafil label
Version not recorded · Effective date not recorded
Excretion — The mean oral clearance for tadalafil is 2.5 L/hr and the mean terminal half-life is 17.5 hours in healthy subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:17947ccd-6f0e-d4cd-e063-6294a90a108a (opens source in a new tab)
Tadalafil label
Version not recorded · Effective date not recorded
Excretion — The mean oral clearance for tadalafil is 2.5 L/hr and the mean terminal half-life is 17.5 hours in healthy subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:13a107ba-cbbd-7760-e063-6394a90a1ee8 (opens source in a new tab)
Tadalafil label
Version not recorded · Effective date not recorded
Excretion — The mean oral clearance for tadalafil is 2.5 L/hr and the mean terminal half-life is 17.5 hours in healthy subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:2a4666e1-4151-f540-e063-6394a90aed0b (opens source in a new tab)
Tadalafil label
Version not recorded · Effective date not recorded
Excretion — The mean oral clearance for tadalafil is 2.5 L/hr and the mean terminal half-life is 17.5 hours in healthy subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:2354c3e2-7b5f-4fdd-bbf2-7fa3c57686f8 (opens source in a new tab)
Tadalafil label
Version not recorded · Effective date not recorded
Excretion — The mean oral clearance for tadalafil is 2.5 L/hr and the mean terminal half-life is 17.5 hours in healthy subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:5de70f00-00ac-4656-883e-d1e07d5f71d6 (opens source in a new tab)
Tadalafil label
Version not recorded · Effective date not recorded
Excretion — The mean oral clearance for tadalafil is 2.5 L/hr and the mean terminal half-life is 17.5 hours in healthy subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:7e236f83-14bf-4862-91fb-74d766aef6a9 (opens source in a new tab)
Tadalafil label
Version not recorded · Effective date not recorded
Excretion — The mean oral clearance for tadalafil is 2.5 L/hr and the mean terminal half-life is 17.5 hours in healthy subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:cd94158b-43fa-44fc-a858-0983770efa83 (opens source in a new tab)
Tadalafil label
Version not recorded · Effective date not recorded
Excretion — The mean oral clearance for tadalafil is 2.5 L/hr and the mean terminal half-life is 17.5 hours in healthy subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:b3a58c17-f260-4125-abd1-27da00bb0719 (opens source in a new tab)
Tadalafil label
Version not recorded · Effective date not recorded
Excretion — The mean oral clearance for tadalafil is 2.5 L/hr and the mean terminal half-life is 17.5 hours in healthy subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:16f13179-7c87-aa6c-e063-6294a90a93eb (opens source in a new tab)
Tadalafil label
Version not recorded · Effective date not recorded
Excretion — The mean oral clearance for tadalafil is 2.5 L/hr and the mean terminal half-life is 17.5 hours in healthy subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:07567ae5-7345-4ab1-9b2c-c586c4da0427 (opens source in a new tab)
Tadalafil label
Version not recorded · Effective date not recorded
Excretion — The mean oral clearance for tadalafil is 2.5 L/hr and the mean terminal half-life is 17.5 hours in healthy subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:a6847ad6-3b5b-47e5-a3b5-04dc3182d72b (opens source in a new tab)
Tadalafil label
Version not recorded · Effective date not recorded
Excretion — The mean oral clearance for tadalafil is 2.5 L/hr and the mean terminal half-life is 17.5 hours in healthy subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:52505a7a-e3dd-7c4e-e063-6294a90a1473 (opens source in a new tab)
Tadalafil label
Version not recorded · Effective date not recorded
Excretion — The mean oral clearance for tadalafil is 2.5 L/hr and the mean terminal half-life is 17.5 hours in healthy subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:7a105ef9-7129-4ce1-bd8d-ae316bf348e2 (opens source in a new tab)
Tadalafil label
Version not recorded · Effective date not recorded
Excretion — The mean oral clearance for tadalafil is 2.5 L/hr and the mean terminal half-life is 17.5 hours in healthy subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:101f44e4-669c-4e3d-843a-a27157750f9c (opens source in a new tab)
Tadalafil label
Version not recorded · Effective date not recorded
Excretion — The mean oral clearance for tadalafil is 2.5 L/hr and the mean terminal half-life is 17.5 hours in healthy subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:0345b81b-f946-4dd6-b49d-2a2bdd4c49c9 (opens source in a new tab)
Tadalafil label
Version not recorded · Effective date not recorded
Excretion — The mean oral clearance for tadalafil is 2.5 L/hr and the mean terminal half-life is 17.5 hours in healthy subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:b9d71483-861b-465b-846b-d7bfd6cbac11 (opens source in a new tab)
Tadalafil label
Version not recorded · Effective date not recorded
Excretion — The mean oral clearance for tadalafil is 2.5 L/hr and the mean terminal half-life is 17.5 hours in healthy subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:d1dd9d05-e9d3-49ea-aeda-047536a27037 (opens source in a new tab)
Tadalafil label
Version not recorded · Effective date not recorded
E xcr etion — The mean oral clearance for tadalafil is 2.5 L/hr and the mean terminal half-life is 17.5 hours in healthy subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:2eae8756-5c7f-2545-e063-6294a90a6d52 (opens source in a new tab)
Tadalafil label
Version not recorded · Effective date not recorded
Excretion — The mean oral clearance for tadalafil is 2.5 L/hr and the mean terminal half-life is 17.5 hours in healthy subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:85ed0cbc-df84-44df-a9eb-f9587dbc21df (opens source in a new tab)
Tadalafil label
Version not recorded · Effective date not recorded
Excretion — The mean oral clearance for tadalafil is 2.5 L/hr and the mean terminal half-life is 17.5 hours in healthy subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:48850075-ac57-abb7-e063-6394a90a7881 (opens source in a new tab)
Tadalafil label
Version not recorded · Effective date not recorded
Excretion — The mean oral clearance for tadalafil is 2.5 L/hr and the mean terminal half-life is 17.5 hours in healthy subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:2121cd9b-a2c0-4f19-a33d-939c6fb3826d (opens source in a new tab)
Tadalafil label
Version not recorded · Effective date not recorded
Excretion — The mean oral clearance for tadalafil is 2.5 L/hr and the mean terminal half-life is 17.5 hours in healthy subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:c835a34a-9bae-4d88-b951-1b78ab92f388 (opens source in a new tab)
Tadalafil label
Version not recorded · Effective date not recorded
Excretion — The mean oral clearance for tadalafil is 2.5 L/hr and the mean terminal half-life is 17.5 hours in healthy subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:05640a4d-afb7-42ae-a5bb-77dbc8412356 (opens source in a new tab)
Tadalafil label
Version not recorded · Effective date not recorded
Excretion — The mean oral clearance for tadalafil is 2.5 L/hr and the mean terminal half-life is 17.5 hours in healthy subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:415bd983-86f3-4f38-917a-9805024f31cb (opens source in a new tab)
Tadalafil label
Version not recorded · Effective date not recorded
Excretion — The mean oral clearance for tadalafil is 2.5 L/hr and the mean terminal half-life is 17.5 hours in healthy subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f9e9a953-2802-4bb1-91a3-a29be347801e (opens source in a new tab)
Tadalafil label
Version not recorded · Effective date not recorded
Excretion — The mean oral clearance for tadalafil is 2.5 L/hr and the mean terminal half-life is 17.5 hours in healthy subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:ac93704f-8e33-43ba-8b56-3d61092ff1d9 (opens source in a new tab)
Tadalafil label
Version not recorded · Effective date not recorded
Excretion — The mean oral clearance for tadalafil is 2.5 L/hr and the mean terminal half-life is 17.5 hours in healthy subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:c1c8feb4-a85a-4f39-8c44-bc9cd77226f4 (opens source in a new tab)
Tadalafil label
Version not recorded · Effective date not recorded
Excretion — The mean oral clearance for tadalafil is 2.5 L/hr and the mean terminal half-life is 17.5 hours in healthy subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:78b6659c-3a46-4998-9151-1a53afd83375 (opens source in a new tab)
Tadalafil label
Version not recorded · Effective date not recorded
Excretion —The mean oral clearance for tadalafil is 2.5 L/hr and the mean terminal half-life is 17.5 hours in healthy subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:b2d163aa-1056-47dd-85aa-297800e6c772 (opens source in a new tab)
Tadalafil label
Version not recorded · Effective date not recorded
Excretion — The mean oral clearance for tadalafil is 2.5 L/hr and the mean terminal half-life is 17.5 hours in healthy subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:828f0ee1-b9fc-4743-9394-fc086bcf5345 (opens source in a new tab)
Tadalafil label
Version not recorded · Effective date not recorded
Excretion —The mean oral clearance for tadalafil is 2.5 L/hr and the mean terminal half-life is 17.5 hours in healthy subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:aa345972-40b4-415e-acb5-31b808a8d815 (opens source in a new tab)
Tadalafil label
Version not recorded · Effective date not recorded
Excretion — The mean oral clearance for tadalafil is 2.5 L/hr and the mean terminal half-life is 17.5 hours in healthy subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:185a3284-3a4f-44d3-9278-98581d33f95b (opens source in a new tab)
Tadalafil label
Version not recorded · Effective date not recorded
Excretion — The mean oral clearance for tadalafil is 2.5 L/hr and the mean terminal half-life is 17.5 hours in healthy subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:b3ee8325-bcb2-43fd-e053-2a95a90a08c8 (opens source in a new tab)
Tadalafil label
Version not recorded · Effective date not recorded
Excretion — The mean oral clearance for tadalafil is 2.5 L/hr and the mean terminal half-life is 17.5 hours in healthy subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:0ea97208-5afc-4943-b35c-ea850203a794 (opens source in a new tab)
Tadalafil label
Version not recorded · Effective date not recorded
Excretion — The mean oral clearance for tadalafil is 2.5 L/hr and the mean terminal half-life is 17.5 hours in healthy subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:2c2ec257-06bc-4ca4-9cf3-d0f49980e374 (opens source in a new tab)
Tadalafil label
Version not recorded · Effective date not recorded
Excretion — The mean oral clearance for tadalafil is 2.5 L/hr and the mean terminal half-life is 17.5 hours in healthy subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:d6e8c52f-4dc3-5d54-e053-2995a90a9358 (opens source in a new tab)
Tadalafil label
Version not recorded · Effective date not recorded
Excretion — The mean oral clearance for tadalafil is 2.5 L/hr and the mean terminal half-life is 17.5 hours in healthy subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:6caf3b55-9bf4-4355-9e25-8bf368943fdd (opens source in a new tab)
Tadalafil label
Version not recorded · Effective date not recorded
Excretion —The mean oral clearance for tadalafil is 2.5 L/hr and the mean terminal half-life is 17.5 hours in healthy subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:3ad14d63-42e7-493f-b56c-e02a4fd139f7 (opens source in a new tab)
Tadalafil label
Version not recorded · Effective date not recorded
Excretion — The mean oral clearance for tadalafil is 2.5 L/hr and the mean terminal half-life is 17.5 hours in healthy subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:e899da81-a28e-4a7e-a0e6-ed6d557c0bcd (opens source in a new tab)
Tadalafil label
Version not recorded · Effective date not recorded
Excretion —The mean oral clearance for tadalafil is 2.5 L/hr and the mean terminal half-life is 17.5 hours in healthy subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:1dace1e7-c617-492f-bb0d-141bf4e673db (opens source in a new tab)
Tadalafil label
Version not recorded · Effective date not recorded
Excretion — The mean oral clearance for tadalafil is 2.5 L/hr and the mean terminal half-life is 17.5 hours in healthy subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:a0acad71-8ae3-2827-e053-2995a90a20b3 (opens source in a new tab)
Tadalafil label
Version not recorded · Effective date not recorded
Excretion — The mean oral clearance for tadalafil is 2.5 L/hr and the mean terminal half-life is 17.5 hours in healthy subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:b4d9851c-5c06-4532-bd82-16d92b60c28f (opens source in a new tab)
Tadalafil label
Version not recorded · Effective date not recorded
Excretion — The mean oral clearance for tadalafil is 2.5 L/hr and the mean terminal half-life is 17.5 hours in healthy subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:0b75f746-866e-3a5b-e063-6294a90a5e02 (opens source in a new tab)
Tadalafil label
Version not recorded · Effective date not recorded
Excretion — The mean oral clearance for tadalafil is 2.5 L/hr and the mean terminal half-life is 17.5 hours in healthy subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:2ad52dff-9fcd-041f-e063-6394a90afcef (opens source in a new tab)
Tadalafil label
Version not recorded · Effective date not recorded
Excretion — The mean oral clearance for tadalafil is 2.5 L/hr and the mean terminal half-life is 17.5 hours in healthy subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:6213fd38-9580-4253-91d2-14c28a711c20 (opens source in a new tab)
Tadalafil label
Version not recorded · Effective date not recorded
Excretion — The mean oral clearance for tadalafil is 2.5 L/hr and the mean terminal half-life is 17.5 hours in healthy subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:fc7596dd-42d3-af7c-e053-6294a90af01e (opens source in a new tab)
Tadalafil label
Version not recorded · Effective date not recorded
Excretion — The mean oral clearance for tadalafil is 2.5 L/hr and the mean terminal half-life is 17.5 hours in healthy subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:cf353da9-31c6-66c2-e053-2995a90a3bb0 (opens source in a new tab)
Tadalafil label
Version not recorded · Effective date not recorded
Excretion — The mean oral clearance for tadalafil is 2.5 L/hr and the mean terminal half-life is 17.5 hours in healthy subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f34e4747-28be-4ae5-ac9a-a825083b6a9b (opens source in a new tab)
Tadalafil label
Version not recorded · Effective date not recorded
Excretion — The mean oral clearance for tadalafil is 2.5 L/hr and the mean terminal half-life is 17.5 hours in healthy subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:bcd8f8ab-81a2-4891-83db-24a0b0e25895 (opens source in a new tab)
Tadalafil label
Version not recorded · Effective date not recorded
Excretion — The mean oral clearance for tadalafil is 2.5 L/hr and the mean terminal half-life is 17.5 hours in healthy subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:89a33a41-0f01-4f29-8b2f-769d649fbdcb (opens source in a new tab)
Tadalafil label
Version not recorded · Effective date not recorded
Excretion — The mean oral clearance for tadalafil is 2.5 L/hr and the mean terminal half-life is 17.5 hours in healthy subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:a0f728b6-2cc6-cb65-e053-2a95a90ab142 (opens source in a new tab)
Tadalafil label
Version not recorded · Effective date not recorded
Excretion — The mean oral clearance for tadalafil is 2.5 L/hr and the mean terminal half-life is 17.5 hours in healthy subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:affacb88-4af3-4ce9-961b-7fc37b169e9a (opens source in a new tab)
Tadalafil label
Version not recorded · Effective date not recorded
Excretion — The mean oral clearance for tadalafil is 2.5 L/hr and the mean terminal half-life is 17.5 hours in healthy subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:2c4108c6-9014-4bd8-e063-6294a90a88fa (opens source in a new tab)
Tadalafil label
Version not recorded · Effective date not recorded
Excretion — The mean oral clearance for tadalafil is 2.5 L/hr and the mean terminal half-life is 17.5 hours in healthy subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:51f87c9b-038c-4793-b0d5-5359ae231074 (opens source in a new tab)
Tadalafil label
Version not recorded · Effective date not recorded
Excretion — The mean oral clearance for tadalafil is 2.5 L/hr and the mean terminal half-life is 17.5 hours in healthy subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:a7b3937e-ff03-436a-a5d4-92a4771034b6 (opens source in a new tab)
Tadalafil label
Version not recorded · Effective date not recorded
Excretion — The mean oral clearance for tadalafil is 2.5 L/hr and the mean terminal half-life is 17.5 hours in healthy subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:add6afb8-d38c-47a2-8c35-d5940667bb0c (opens source in a new tab)
Tadalafil label
Version not recorded · Effective date not recorded
Excretion — The mean oral clearance for tadalafil is 2.5 L/hr and the mean terminal half-life is 17.5 hours in healthy subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:34684fe8-9bf3-47fd-e063-6394a90ac80f (opens source in a new tab)
Tadalafil label
Version not recorded · Effective date not recorded
Excretion — The mean oral clearance for tadalafil is 2.5 L/hr and the mean terminal half-life is 17.5 hours in healthy subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:66e24ced-0008-40cb-b242-9d9add1f665c (opens source in a new tab)
Tadalafil label
Version not recorded · Effective date not recorded
Excretion — The mean oral clearance for tadalafil is 2.5 L/hr and the mean terminal half-life is 17.5 hours in healthy subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:168a135b-1454-4def-9b03-c9a470bfcb5f (opens source in a new tab)
Tadalafil label
Version not recorded · Effective date not recorded
Excretion - The mean oral clearance for tadalafil is 2.5 L/hr and the mean terminal half-life is 17.5 hours in healthy subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:b96ae7f1-7d4a-a211-e053-2995a90ab6e2 (opens source in a new tab)
Tadalafil label
Version not recorded · Effective date not recorded
E xcr etion — The mean oral clearance for tadalafil is 2.5 L/hr and the mean terminal half-life is 17.5 hours in healthy subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:491cb72b-71f2-4df9-99f8-c02d93500103 (opens source in a new tab)
Tadalafil label
Version not recorded · Effective date not recorded
Excretion — The mean oral clearance for tadalafil is 2.5 L/hr and the mean terminal half-life is 17.5 hours in healthy subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:7e4cdac1-42cc-4038-a86b-4890962ed806 (opens source in a new tab)
Tadalafil label
Version not recorded · Effective date not recorded
Excretion — The mean oral clearance for tadalafil is 2.5 L/hr and the mean terminal half-life is 17.5 hours in healthy subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:90f38460-62ad-492e-a3da-403d5a5a5d86 (opens source in a new tab)
Tadalafil label
Version not recorded · Effective date not recorded
E xcr etion — The mean oral clearance for tadalafil is 2.5 L/hr and the mean terminal half-life is 17.5 hours in healthy subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:a2e7f393-5cfc-45e5-b87d-9e8abc8e4355 (opens source in a new tab)
Tadalafil label
Version not recorded · Effective date not recorded
Excretion — The mean oral clearance for tadalafil is 2.5 L/hr and the mean terminal half-life is 17.5 hours in healthy subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:7dfb450b-4d39-40e7-b115-9a96023052a0 (opens source in a new tab)
Tadalafil label
Version not recorded · Effective date not recorded
Excretion —The mean oral clearance for tadalafil is 2.5 L/hr and the mean terminal half-life is 17.5 hours in healthy subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:ff3c7dd3-2dcc-498c-a121-1e2aa62c7a97 (opens source in a new tab)
Tadalafil label
Version not recorded · Effective date not recorded
Excretion — The mean oral clearance for tadalafil is 2.5 L/hr and the mean terminal half-life is 17.5 hours in healthy subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:00cbc656-768d-4995-bb6d-a0d4b32a248c (opens source in a new tab)
Tadalafil label
Version not recorded · Effective date not recorded
Excretion — The mean oral clearance for tadalafil is 2.5 L/hr and the mean terminal half-life is 17.5 hours in healthy subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:bce03930-14c5-401f-ad17-06b7709983bc (opens source in a new tab)
Tadalafil label
Version not recorded · Effective date not recorded
E xcr etion — The mean oral clearance for tadalafil is 2.5 L/hr and the mean terminal half-life is 17.5 hours in healthy subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:24b82a6a-1b7e-42e6-b29b-41d4ee4d525f (opens source in a new tab)
Tadalafil label
Version not recorded · Effective date not recorded
Excretion — The mean oral clearance for tadalafil is 2.5 L/hr and the mean terminal half-life is 17.5 hours in healthy subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:31f5dc06-50f8-47cf-e063-6294a90ad5fb (opens source in a new tab)
Tadalafil label
Version not recorded · Effective date not recorded
Excretion — The mean oral clearance for tadalafil is 2.5 L/hr and the mean terminal half-life is 17.5 hours in healthy subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:7976c4ec-ecc4-4a49-a4fe-f990aece2d3c (opens source in a new tab)
Tadalafil label
Version not recorded · Effective date not recorded
Excretion — The mean oral clearance for tadalafil is 2.5 L/hr and the mean terminal half-life is 17.5 hours in healthy subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:4348b7db-e5b2-4e87-8cdd-674797a18890 (opens source in a new tab)
Tadalafil label
Version not recorded · Effective date not recorded
Excretion — The mean oral clearance for tadalafil is 2.5 L/hr and the mean terminal half-life is 17.5 hours in healthy subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:fa547e3d-455a-4926-9fd9-349930898502 (opens source in a new tab)
Tadalafil label
Version not recorded · Effective date not recorded
Excretion — The mean oral clearance for tadalafil is 2.5 L/hr and the mean terminal half-life is 17.5 hours in healthy subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:dc14daa3-cae9-4751-9034-b0e9c18054b4 (opens source in a new tab)
Tadalafil label
Version not recorded · Effective date not recorded
Excretion — The mean oral clearance for tadalafil is 2.5 L/hr and the mean terminal half-life is 17.5 hours in healthy subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:248a4705-1403-e94a-e063-6294a90a3544 (opens source in a new tab)
Tadalafil label
Version not recorded · Effective date not recorded
Excretion — The mean oral clearance for tadalafil is 2.5 L/hr and the mean terminal half-life is 17.5 hours in healthy subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:22b8a2e3-d1b8-f193-45fa-77cc62a1b941 (opens source in a new tab)
Tadalafil label
Version not recorded · Effective date not recorded
Excretion — The mean oral clearance for tadalafil is 2.5 L/hr and the mean terminal half-life is 17.5 hours in healthy subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:a73b0e6f-09fc-42d6-a678-1409ce746bd1 (opens source in a new tab)
Tadalafil label
Version not recorded · Effective date not recorded
Excretion - The mean oral clearance for tadalafil is 2.5 L/hr and the mean terminal half-life is 17.5 hours in healthy subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:2cad2167-dbd1-4df8-b407-b270487d027b (opens source in a new tab)
Tadalafil label
Version not recorded · Effective date not recorded
E xcr etion — The mean oral clearance for tadalafil is 2.5 L/hr and the mean terminal half-life is 17.5 hours in healthy subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f2a132af-d75e-2ca0-e053-2a95a90a332e (opens source in a new tab)
Tadalafil label
Version not recorded · Effective date not recorded
Excretion The mean oral clearance for tadalafil is 2.5 L/hr and the mean terminal half-life is 17.5 hours in healthy subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:ae801b15-0462-44af-99a4-affe3eed899a (opens source in a new tab)
Tadalafil label
Version not recorded · Effective date not recorded
Excretion — The mean oral clearance for tadalafil is 2.5 L/hr and the mean terminal half-life is 17.5 hours in healthy subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:78509a43-a907-4359-9022-f38c4f765880 (opens source in a new tab)
Tadalafil label
Version not recorded · Effective date not recorded
Excretion — The mean oral clearance for tadalafil is 2.5 L/hr and the mean terminal half-life is 17.5 hours in healthy subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:82dfea4c-9fe5-438a-917f-8f7d395ee8ca (opens source in a new tab)
Tadalafil label
Version not recorded · Effective date not recorded
Excretion — The mean oral clearance for tadalafil is 2.5 L/hr and the mean terminal half-life is 17.5 hours in healthy subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f8def23c-55ea-4796-9735-dbcb25104835 (opens source in a new tab)
Tadalafil label
Version not recorded · Effective date not recorded
Excretion — The mean oral clearance for tadalafil is 2.5 L/hr and the mean terminal half-life is 17.5 hours in healthy subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:48892acb-43bb-a4d8-e063-6394a90a5d61 (opens source in a new tab)
Tadalafil label
Version not recorded · Effective date not recorded
Excretion — The mean oral clearance for tadalafil is 2.5 L/hr and the mean terminal half-life is 17.5 hours in healthy subjects.
15 hours
- Numeric value
- 15
- Unit
- hours
- Source records
- 16
Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.
Show all 16 source records
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:a0ecc7cf-20dd-485a-b4dd-1bbc587280a7 (opens source in a new tab)
Tadalafil label
Version not recorded · Effective date not recorded
Elimination — Following 40 mg, the mean oral clearance for tadalafil is 3.4 L/hr and the mean terminal half-life is 15 hours in healthy subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:84cb16c8-30ab-49f2-a6df-ec3c97bf6284 (opens source in a new tab)
Tadalafil label
Version not recorded · Effective date not recorded
Elimination — Following 40 mg, the mean oral clearance for tadalafil is 3.4 L/hr and the mean terminal half-life is 15 hours in healthy subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:efa03afa-c412-4b31-bf26-7c3a6f7311af (opens source in a new tab)
Tadalafil label
Version not recorded · Effective date not recorded
Elimination Following 40 mg, the mean oral clearance for tadalafil is 3.4 L/hr and the mean terminal half-life is 15 hours in healthy subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:cec49f6c-71f1-4de7-b515-1612ae16e5db (opens source in a new tab)
Tadalafil label
Version not recorded · Effective date not recorded
Elimination — Following 40 mg, the mean oral clearance for tadalafil is 3.4 L/hr and the mean terminal half-life is 15 hours in healthy subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:dc0a6a03-5ef1-4507-b888-5b559653c3e9 (opens source in a new tab)
Tadalafil label
Version not recorded · Effective date not recorded
Elimination — Following 40 mg, the mean oral clearance for tadalafil is 3.4 L/hr and the mean terminal half-life is 15 hours in healthy subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:93dd604f-8f38-4600-afe8-0fcc92fd2497 (opens source in a new tab)
Tadalafil label
Version not recorded · Effective date not recorded
Elimination — Following 40 mg, the mean oral clearance for tadalafil is 3.4 L/hr and the mean terminal half-life is 15 hours in healthy subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:88132351-7fee-47ef-8007-ef2777543299 (opens source in a new tab)
Tadalafil label
Version not recorded · Effective date not recorded
Elimination — Following 40 mg, the mean oral clearance for tadalafil is 3.4 L/hr and the mean terminal half-life is 15 hours in healthy subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:9489b635-385e-4a05-be02-df39fcafebe3 (opens source in a new tab)
Tadalafil label
Version not recorded · Effective date not recorded
Elimination — Following 40 mg, the mean oral clearance for tadalafil is 3.4 L/hr and the mean terminal half-life is 15 hours in healthy subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:3c1c2136-099f-6232-e063-6294a90a6975 (opens source in a new tab)
Tadalafil label
Version not recorded · Effective date not recorded
Elimination — Following 40 mg, the mean oral clearance for tadalafil is 3.4 L/hr and the mean terminal half-life is 15 hours in healthy subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:cf6fc925-ad20-4ed0-9356-15d24afa8d0b (opens source in a new tab)
Tadalafil label
Version not recorded · Effective date not recorded
Elimination — Following 40 mg, the mean oral clearance for tadalafil is 3.4 L/hr and the mean terminal half-life is 15 hours in healthy subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:0afd0728-256a-293b-e063-6394a90a3c5f (opens source in a new tab)
Tadalafil label
Version not recorded · Effective date not recorded
Elimination — Following 40 mg, the mean oral clearance for tadalafil is 3.4 L/hr and the mean terminal half-life is 15 hours in healthy subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:2faa7a55-3054-456b-8465-6ea6dc1c0aa9 (opens source in a new tab)
Tadalafil label
Version not recorded · Effective date not recorded
Elimination - Following 40 mg, the mean oral clearance for tadalafil is 3.4 L/hr and the mean terminal half-life is 15 hours in healthy subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:fceb8aaf-b4eb-4004-8ca4-f004eac6b314 (opens source in a new tab)
Tadalafil label
Version not recorded · Effective date not recorded
Elimination — Following 40 mg, the mean oral clearance for tadalafil is 3.4 L/hr and the mean terminal half-life is 15 hours in healthy subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:7a909b25-3772-403e-a5fe-e4a040293fb7 (opens source in a new tab)
Tadalafil label
Version not recorded · Effective date not recorded
Elimination — Following 40 mg, the mean oral clearance for tadalafil is 3.4 L/hr and the mean terminal half-life is 15 hours in healthy subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:ff61b237-be8e-461b-8114-78c52a8ad0ae (opens source in a new tab)
Tadalafil label
Version not recorded · Effective date not recorded
Elimination — Following 40 mg, the mean oral clearance for tadalafil is 3.4 L/hr and the mean terminal half-life is 15 hours in healthy subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:61955171-ca57-e300-1983-9472a56ca976 (opens source in a new tab)
Tadalafil label
Version not recorded · Effective date not recorded
Elimination — Following 40 mg, the mean oral clearance for tadalafil is 3.4 L/hr and the mean terminal half-life is 15 hours in healthy subjects.
Projected row 1445
- Medicine slug
- tadalafil
- Compared field
- volumeOfDistribution
- Comparison state
- insufficient_context
- Reason codes
- STRUCTURED_CONTEXT_MISSING
- Documents examined
- 141
- Source count
- 141
- Agreement rate
- 0.886525
- Recorded readings
63 L
- Numeric value
- 63
- Unit
- L
- Source records
- 125
Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.
Show all 125 source records
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:36350106-98bc-41fc-bede-8be5e6f54a8a (opens source in a new tab)
Tadalafil label
Version not recorded · Effective date not recorded
Distribution — The mean apparent volume of distribution following oral administration is approximately 63 L, indicating that tadalafil is distributed into tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:a3190ceb-fb3f-45f7-a12d-4c333edaadc6 (opens source in a new tab)
Tadalafil label
Version not recorded · Effective date not recorded
Distribution - The mean apparent volume of distribution following oral administration is approximately 63 L, indicating that tadalafil is distributed into tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:594acc15-a5bc-43b5-9659-a864b2c46eea (opens source in a new tab)
Tadalafil label
Version not recorded · Effective date not recorded
Distribution - The mean apparent volume of distribution following oral administration is approximately 63 L, indicating that tadalafil is distributed into tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:31c05a53-7282-46d0-81bd-108defe6fb38 (opens source in a new tab)
Tadalafil label
Version not recorded · Effective date not recorded
Distribution — The mean apparent volume of distribution following oral administration is approximately 63 L, indicating that tadalafil is distributed into tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:a930511d-110e-4d2e-a4ca-df712f968b2d (opens source in a new tab)
Tadalafil label
Version not recorded · Effective date not recorded
Distribution —The mean apparent volume of distribution following oral administration is approximately 63 L, indicating that tadalafil is distributed into tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:0a9cf85a-c17d-6890-e063-6394a90a93e9 (opens source in a new tab)
Tadalafil label
Version not recorded · Effective date not recorded
Distribution — The mean apparent volume of distribution following oral administration is approximately 63 L, indicating that tadalafil is distributed into tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:716c586d-e524-4f3e-ab1d-7ef9184169d9 (opens source in a new tab)
Tadalafil label
Version not recorded · Effective date not recorded
Distribution — The mean apparent volume of distribution following oral administration is approximately 63 L, indicating that tadalafil is distributed into tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:09ad27a1-3908-4533-b84c-7a7fd3514101 (opens source in a new tab)
Tadalafil label
Version not recorded · Effective date not recorded
Distribution — The mean apparent volume of distribution following oral administration is approximately 63 L, indicating that tadalafil is distributed into tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:761dc0f8-2f65-4615-ab49-a4bcffd40ce9 (opens source in a new tab)
Tadalafil label
Version not recorded · Effective date not recorded
Distribution — The mean apparent volume of distribution following oral administration is approximately 63 L, indicating that tadalafil is distributed into tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:741102c1-8809-44d4-9098-3dc8c0604764 (opens source in a new tab)
Tadalafil label
Version not recorded · Effective date not recorded
Distribution - The mean apparent volume of distribution following oral administration is approximately 63 L, indicating that tadalafil is distributed into tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f317fe1e-d7c4-fb8b-e053-2a95a90a5445 (opens source in a new tab)
Tadalafil label
Version not recorded · Effective date not recorded
Distribution — The mean apparent volume of distribution following oral administration is approximately 63 L, indicating that tadalafil is distributed into tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:ad288e9d-020a-43a0-9c07-320c5c3bbc1e (opens source in a new tab)
Tadalafil label
Version not recorded · Effective date not recorded
Distribution — The mean apparent volume of distribution following oral administration is approximately 63 L, indicating that tadalafil is distributed into tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:eedf3ad9-7d40-496d-b1a9-6200010c18e1 (opens source in a new tab)
Tadalafil label
Version not recorded · Effective date not recorded
Distribution — The mean apparent volume of distribution following oral administration is approximately 63 L, indicating that tadalafil is distributed into tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:351e28ca-3ae6-e535-e063-6394a90a9fb7 (opens source in a new tab)
Tadalafil label
Version not recorded · Effective date not recorded
Distribution — The mean apparent volume of distribution following oral administration is approximately 63 L, indicating that tadalafil is distributed into tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f2e8821e-04c9-4812-8c9e-39340775cc6e (opens source in a new tab)
Tadalafil label
Version not recorded · Effective date not recorded
Distribution — The mean apparent volume of distribution following oral administration is approximately 63 L, indicating that tadalafil is distributed into tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f295f164-78fb-4224-b319-9f20b7a453b5 (opens source in a new tab)
Tadalafil label
Version not recorded · Effective date not recorded
Distribution — The mean apparent volume of distribution following oral administration is approximately 63 L, indicating that tadalafil is distributed into tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:aba646fe-70c2-1abb-e053-2995a90aa16d (opens source in a new tab)
Tadalafil label
Version not recorded · Effective date not recorded
Distribution — The mean apparent volume of distribution following oral administration is approximately 63 L, indicating that tadalafil is distributed into tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:6fd94914-0c9d-4268-8ed8-3c2690707a5d (opens source in a new tab)
Tadalafil label
Version not recorded · Effective date not recorded
Distribution - The mean apparent volume of distribution following oral administration is approximately 63 L, indicating that tadalafil is distributed into tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:cfe43ab8-8721-4db8-8810-f0072cf8f4d3 (opens source in a new tab)
Tadalafil label
Version not recorded · Effective date not recorded
Distribution The mean apparent volume of distribution following oral administration is approximately 63 L, indicating that tadalafil is distributed into tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:30ae58ed-5b56-4513-8eb3-eb4f89b78f9d (opens source in a new tab)
Tadalafil label
Version not recorded · Effective date not recorded
Distribution - The mean apparent volume of distribution following oral administration is approximately 63 L, indicating that tadalafil is distributed into tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:9f83ea2e-8ee8-ab6d-e053-2995a90a1e96 (opens source in a new tab)
Tadalafil label
Version not recorded · Effective date not recorded
Distribution — The mean apparent volume of distribution following oral administration is approximately 63 L, indicating that tadalafil is distributed into tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:a84c1eab-5934-4e5d-8bb2-0734d6adba6a (opens source in a new tab)
Tadalafil label
Version not recorded · Effective date not recorded
Distribution - The mean apparent volume of distribution following oral administration is approximately 63 L, indicating that tadalafil is distributed into tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:1580ab76-e229-4b8d-8c7b-82f39fecfebd (opens source in a new tab)
Tadalafil label
Version not recorded · Effective date not recorded
Distribution - The mean apparent volume of distribution following oral administration is approximately 63 L, indicating that tadalafil is distributed into tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f3092f5a-b976-91ab-e053-2995a90a9b50 (opens source in a new tab)
Tadalafil label
Version not recorded · Effective date not recorded
Distribution — The mean apparent volume of distribution following oral administration is approximately 63 L, indicating that tadalafil is distributed into tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:5ea24573-2d16-40d8-a46c-7b5fa8669e69 (opens source in a new tab)
Tadalafil label
Version not recorded · Effective date not recorded
Distribution — The mean apparent volume of distribution following oral administration is approximately 63 L, indicating that tadalafil is distributed into tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:c3409762-3b2b-1cfc-e053-2995a90ab91b (opens source in a new tab)
Tadalafil label
Version not recorded · Effective date not recorded
Distribution — The mean apparent volume of distribution following oral administration is approximately 63 L, indicating that tadalafil is distributed into tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:fee8c2be-ccfa-4c66-abed-5e232ec762ae (opens source in a new tab)
Tadalafil label
Version not recorded · Effective date not recorded
Distribution — The mean apparent volume of distribution following oral administration is approximately 63 L, indicating that tadalafil is distributed into tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:2c277890-3c5d-5fd5-e063-6394a90af15b (opens source in a new tab)
Tadalafil label
Version not recorded · Effective date not recorded
Distribution — The mean apparent volume of distribution following oral administration is approximately 63 L, indicating that tadalafil is distributed into tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:351de7c2-98bf-7c88-e063-6294a90ad811 (opens source in a new tab)
Tadalafil label
Version not recorded · Effective date not recorded
Distribution — The mean apparent volume of distribution following oral administration is approximately 63 L, indicating that tadalafil is distributed into tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:a3892605-4eb1-4d6e-a675-f7f7d4302f38 (opens source in a new tab)
Tadalafil label
Version not recorded · Effective date not recorded
Distribution — The mean apparent volume of distribution following oral administration is approximately 63 L, indicating that tadalafil is distributed into tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:6fa9d4fa-86c9-4791-b28b-78e8b9341cea (opens source in a new tab)
Tadalafil label
Version not recorded · Effective date not recorded
Distribution — The mean apparent volume of distribution following oral administration is approximately 63 L, indicating that tadalafil is distributed into tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:929e391e-b74b-4ccd-8690-16ffcece7a30 (opens source in a new tab)
Tadalafil label
Version not recorded · Effective date not recorded
Distribution — The mean apparent volume of distribution following oral administration is approximately 63 L, indicating that tadalafil is distributed into tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:cf35291b-b05b-1182-e053-2995a90a8dee (opens source in a new tab)
Tadalafil label
Version not recorded · Effective date not recorded
Distribution — The mean apparent volume of distribution following oral administration is approximately 63 L, indicating that tadalafil is distributed into tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:b1840f16-a7ea-44bd-b091-5268990aedb2 (opens source in a new tab)
Tadalafil label
Version not recorded · Effective date not recorded
Distribution — The mean apparent volume of distribution following oral administration is approximately 63 L, indicating that tadalafil is distributed into tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:abcb2cda-9b3f-45f6-ad5f-c2370b0dd114 (opens source in a new tab)
Tadalafil label
Version not recorded · Effective date not recorded
Distribution - The mean apparent volume of distribution following oral administration is approximately 63 L, indicating that tadalafil is distributed into tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:6c680b37-d515-4fc2-83e6-411f1017e18c (opens source in a new tab)
Tadalafil label
Version not recorded · Effective date not recorded
Distribution — The mean apparent volume of distribution following oral administration is approximately 63 L, indicating that tadalafil is distributed into tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:3ea7612b-b004-43ef-accc-34c8ec5146b8 (opens source in a new tab)
Tadalafil label
Version not recorded · Effective date not recorded
Distribution — The mean apparent volume of distribution following oral administration is approximately 63 L, indicating that tadalafil is distributed into tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:aa8d165b-0c7d-497a-b56a-7c62ebc0a5d2 (opens source in a new tab)
Tadalafil label
Version not recorded · Effective date not recorded
Distribution — The mean apparent volume of distribution following oral administration is approximately 63 L, indicating that tadalafil is distributed into tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:a10d464a-6ea7-4e5a-befa-71eceacc5039 (opens source in a new tab)
Tadalafil label
Version not recorded · Effective date not recorded
Distribution —The mean apparent volume of distribution following oral administration is approximately 63 L, indicating that tadalafil is distributed into tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:ca1d46e3-ad9b-48c7-bb7f-63ee678ccf7a (opens source in a new tab)
Tadalafil label
Version not recorded · Effective date not recorded
Distribution —The mean apparent volume of distribution following oral administration is approximately 63 L, indicating that tadalafil is distributed into tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:b539e862-d5d4-4989-a3dd-1eba66285d53 (opens source in a new tab)
Tadalafil label
Version not recorded · Effective date not recorded
Distribution — The mean apparent volume of distribution following oral administration is approximately 63 L, indicating that tadalafil is distributed into tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:17947ccd-6f0e-d4cd-e063-6294a90a108a (opens source in a new tab)
Tadalafil label
Version not recorded · Effective date not recorded
Distribution — The mean apparent volume of distribution following oral administration is approximately 63 L, indicating that tadalafil is distributed into tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:13a107ba-cbbd-7760-e063-6394a90a1ee8 (opens source in a new tab)
Tadalafil label
Version not recorded · Effective date not recorded
Distribution — The mean apparent volume of distribution following oral administration is approximately 63 L, indicating that tadalafil is distributed into tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:2a4666e1-4151-f540-e063-6394a90aed0b (opens source in a new tab)
Tadalafil label
Version not recorded · Effective date not recorded
Distribution — The mean apparent volume of distribution following oral administration is approximately 63 L, indicating that tadalafil is distributed into tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:2354c3e2-7b5f-4fdd-bbf2-7fa3c57686f8 (opens source in a new tab)
Tadalafil label
Version not recorded · Effective date not recorded
Distribution — The mean apparent volume of distribution following oral administration is approximately 63 L, indicating that tadalafil is distributed into tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:5de70f00-00ac-4656-883e-d1e07d5f71d6 (opens source in a new tab)
Tadalafil label
Version not recorded · Effective date not recorded
Distribution — The mean apparent volume of distribution following oral administration is approximately 63 L, indicating that tadalafil is distributed into tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:7e236f83-14bf-4862-91fb-74d766aef6a9 (opens source in a new tab)
Tadalafil label
Version not recorded · Effective date not recorded
Distribution — The mean apparent volume of distribution following oral administration is approximately 63 L, indicating that tadalafil is distributed into tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:cd94158b-43fa-44fc-a858-0983770efa83 (opens source in a new tab)
Tadalafil label
Version not recorded · Effective date not recorded
Distribution — The mean apparent volume of distribution following oral administration is approximately 63 L, indicating that tadalafil is distributed into tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:b3a58c17-f260-4125-abd1-27da00bb0719 (opens source in a new tab)
Tadalafil label
Version not recorded · Effective date not recorded
Distribution — The mean apparent volume of distribution following oral administration is approximately 63 L, indicating that tadalafil is distributed into tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:16f13179-7c87-aa6c-e063-6294a90a93eb (opens source in a new tab)
Tadalafil label
Version not recorded · Effective date not recorded
Distribution — The mean apparent volume of distribution following oral administration is approximately 63 L, indicating that tadalafil is distributed into tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:07567ae5-7345-4ab1-9b2c-c586c4da0427 (opens source in a new tab)
Tadalafil label
Version not recorded · Effective date not recorded
Distribution — The mean apparent volume of distribution following oral administration is approximately 63 L, indicating that tadalafil is distributed into tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:a6847ad6-3b5b-47e5-a3b5-04dc3182d72b (opens source in a new tab)
Tadalafil label
Version not recorded · Effective date not recorded
Distribution — The mean apparent volume of distribution following oral administration is approximately 63 L, indicating that tadalafil is distributed into tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:52505a7a-e3dd-7c4e-e063-6294a90a1473 (opens source in a new tab)
Tadalafil label
Version not recorded · Effective date not recorded
Distribution — The mean apparent volume of distribution following oral administration is approximately 63 L, indicating that tadalafil is distributed into tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:7a105ef9-7129-4ce1-bd8d-ae316bf348e2 (opens source in a new tab)
Tadalafil label
Version not recorded · Effective date not recorded
Distribution — The mean apparent volume of distribution following oral administration is approximately 63 L, indicating that tadalafil is distributed into tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:101f44e4-669c-4e3d-843a-a27157750f9c (opens source in a new tab)
Tadalafil label
Version not recorded · Effective date not recorded
Distribution — The mean apparent volume of distribution following oral administration is approximately 63 L, indicating that tadalafil is distributed into tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:0345b81b-f946-4dd6-b49d-2a2bdd4c49c9 (opens source in a new tab)
Tadalafil label
Version not recorded · Effective date not recorded
Distribution — The mean apparent volume of distribution following oral administration is approximately 63 L, indicating that tadalafil is distributed into tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:b9d71483-861b-465b-846b-d7bfd6cbac11 (opens source in a new tab)
Tadalafil label
Version not recorded · Effective date not recorded
Distribution — The mean apparent volume of distribution following oral administration is approximately 63 L, indicating that tadalafil is distributed into tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:d1dd9d05-e9d3-49ea-aeda-047536a27037 (opens source in a new tab)
Tadalafil label
Version not recorded · Effective date not recorded
Distribution — The mean apparent volume of distribution following oral administration is approximately 63 L, indicating that tadalafil is distributed into tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:2eae8756-5c7f-2545-e063-6294a90a6d52 (opens source in a new tab)
Tadalafil label
Version not recorded · Effective date not recorded
Distribution — The mean apparent volume of distribution following oral administration is approximately 63 L, indicating that tadalafil is distributed into tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:85ed0cbc-df84-44df-a9eb-f9587dbc21df (opens source in a new tab)
Tadalafil label
Version not recorded · Effective date not recorded
Distribution — The mean apparent volume of distribution following oral administration is approximately 63 L, indicating that tadalafil is distributed into tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:48850075-ac57-abb7-e063-6394a90a7881 (opens source in a new tab)
Tadalafil label
Version not recorded · Effective date not recorded
Distribution — The mean apparent volume of distribution following oral administration is approximately 63 L, indicating that tadalafil is distributed into tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:2121cd9b-a2c0-4f19-a33d-939c6fb3826d (opens source in a new tab)
Tadalafil label
Version not recorded · Effective date not recorded
Distribution — The mean apparent volume of distribution following oral administration is approximately 63 L, indicating that tadalafil is distributed into tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:c835a34a-9bae-4d88-b951-1b78ab92f388 (opens source in a new tab)
Tadalafil label
Version not recorded · Effective date not recorded
Distribution — The mean apparent volume of distribution following oral administration is approximately 63 L, indicating that tadalafil is distributed into tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:05640a4d-afb7-42ae-a5bb-77dbc8412356 (opens source in a new tab)
Tadalafil label
Version not recorded · Effective date not recorded
Distribution — The mean apparent volume of distribution following oral administration is approximately 63 L, indicating that tadalafil is distributed into tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:415bd983-86f3-4f38-917a-9805024f31cb (opens source in a new tab)
Tadalafil label
Version not recorded · Effective date not recorded
Distribution — The mean apparent volume of distribution following oral administration is approximately 63 L, indicating that tadalafil is distributed into tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f9e9a953-2802-4bb1-91a3-a29be347801e (opens source in a new tab)
Tadalafil label
Version not recorded · Effective date not recorded
Distribution — The mean apparent volume of distribution following oral administration is approximately 63 L, indicating that tadalafil is distributed into tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:ac93704f-8e33-43ba-8b56-3d61092ff1d9 (opens source in a new tab)
Tadalafil label
Version not recorded · Effective date not recorded
Distribution — The mean apparent volume of distribution following oral administration is approximately 63 L, indicating that tadalafil is distributed into tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:c1c8feb4-a85a-4f39-8c44-bc9cd77226f4 (opens source in a new tab)
Tadalafil label
Version not recorded · Effective date not recorded
Distribution — The mean apparent volume of distribution following oral administration is approximately 63 L, indicating that tadalafil is distributed into tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:78b6659c-3a46-4998-9151-1a53afd83375 (opens source in a new tab)
Tadalafil label
Version not recorded · Effective date not recorded
Distribution —The mean apparent volume of distribution following oral administration is approximately 63 L, indicating that tadalafil is distributed into tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:b2d163aa-1056-47dd-85aa-297800e6c772 (opens source in a new tab)
Tadalafil label
Version not recorded · Effective date not recorded
Distribution — The mean apparent volume of distribution following oral administration is approximately 63 L, indicating that tadalafil is distributed into tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:828f0ee1-b9fc-4743-9394-fc086bcf5345 (opens source in a new tab)
Tadalafil label
Version not recorded · Effective date not recorded
Distribution —The mean apparent volume of distribution following oral administration is approximately 63 L, indicating that tadalafil is distributed into tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:aa345972-40b4-415e-acb5-31b808a8d815 (opens source in a new tab)
Tadalafil label
Version not recorded · Effective date not recorded
Distribution — The mean apparent volume of distribution following oral administration is approximately 63 L, indicating that tadalafil is distributed into tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:185a3284-3a4f-44d3-9278-98581d33f95b (opens source in a new tab)
Tadalafil label
Version not recorded · Effective date not recorded
Distribution — The mean apparent volume of distribution following oral administration is approximately 63 L, indicating that tadalafil is distributed into tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:b3ee8325-bcb2-43fd-e053-2a95a90a08c8 (opens source in a new tab)
Tadalafil label
Version not recorded · Effective date not recorded
Distribution — The mean apparent volume of distribution following oral administration is approximately 63 L, indicating that tadalafil is distributed into tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:0ea97208-5afc-4943-b35c-ea850203a794 (opens source in a new tab)
Tadalafil label
Version not recorded · Effective date not recorded
Distribution — The mean apparent volume of distribution following oral administration is approximately 63 L, indicating that tadalafil is distributed into tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:2c2ec257-06bc-4ca4-9cf3-d0f49980e374 (opens source in a new tab)
Tadalafil label
Version not recorded · Effective date not recorded
Distribution — The mean apparent volume of distribution following oral administration is approximately 63 L, indicating that tadalafil is distributed into tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:d6e8c52f-4dc3-5d54-e053-2995a90a9358 (opens source in a new tab)
Tadalafil label
Version not recorded · Effective date not recorded
Distribution — The mean apparent volume of distribution following oral administration is approximately 63 L, indicating that tadalafil is distributed into tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:6caf3b55-9bf4-4355-9e25-8bf368943fdd (opens source in a new tab)
Tadalafil label
Version not recorded · Effective date not recorded
Distribution —The mean apparent volume of distribution following oral administration is approximately 63 L, indicating that tadalafil is distributed into tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:3ad14d63-42e7-493f-b56c-e02a4fd139f7 (opens source in a new tab)
Tadalafil label
Version not recorded · Effective date not recorded
Distribution — The mean apparent volume of distribution following oral administration is approximately 63 L, indicating that tadalafil is distributed into tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:e899da81-a28e-4a7e-a0e6-ed6d557c0bcd (opens source in a new tab)
Tadalafil label
Version not recorded · Effective date not recorded
Distribution —The mean apparent volume of distribution following oral administration is approximately 63 L, indicating that tadalafil is distributed into tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:1dace1e7-c617-492f-bb0d-141bf4e673db (opens source in a new tab)
Tadalafil label
Version not recorded · Effective date not recorded
Distribution — The mean apparent volume of distribution following oral administration is approximately 63 L, indicating that tadalafil is distributed into tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:a0acad71-8ae3-2827-e053-2995a90a20b3 (opens source in a new tab)
Tadalafil label
Version not recorded · Effective date not recorded
Distribution — The mean apparent volume of distribution following oral administration is approximately 63 L, indicating that tadalafil is distributed into tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:b4d9851c-5c06-4532-bd82-16d92b60c28f (opens source in a new tab)
Tadalafil label
Version not recorded · Effective date not recorded
Distribution — The mean apparent volume of distribution following oral administration is approximately 63 L, indicating that tadalafil is distributed into tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:0b75f746-866e-3a5b-e063-6294a90a5e02 (opens source in a new tab)
Tadalafil label
Version not recorded · Effective date not recorded
Distribution — The mean apparent volume of distribution following oral administration is approximately 63 L, indicating that tadalafil is distributed into tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:2ad52dff-9fcd-041f-e063-6394a90afcef (opens source in a new tab)
Tadalafil label
Version not recorded · Effective date not recorded
Distribution — The mean apparent volume of distribution following oral administration is approximately 63 L, indicating that tadalafil is distributed into tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:6213fd38-9580-4253-91d2-14c28a711c20 (opens source in a new tab)
Tadalafil label
Version not recorded · Effective date not recorded
Distribution — The mean apparent volume of distribution following oral administration is approximately 63 L, indicating that tadalafil is distributed into tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:fc7596dd-42d3-af7c-e053-6294a90af01e (opens source in a new tab)
Tadalafil label
Version not recorded · Effective date not recorded
Distribution — The mean apparent volume of distribution following oral administration is approximately 63 L, indicating that tadalafil is distributed into tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:cf353da9-31c6-66c2-e053-2995a90a3bb0 (opens source in a new tab)
Tadalafil label
Version not recorded · Effective date not recorded
Distribution — The mean apparent volume of distribution following oral administration is approximately 63 L, indicating that tadalafil is distributed into tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f34e4747-28be-4ae5-ac9a-a825083b6a9b (opens source in a new tab)
Tadalafil label
Version not recorded · Effective date not recorded
Distribution — The mean apparent volume of distribution following oral administration is approximately 63 L, indicating that tadalafil is distributed into tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:bcd8f8ab-81a2-4891-83db-24a0b0e25895 (opens source in a new tab)
Tadalafil label
Version not recorded · Effective date not recorded
Figure Distribution — The mean apparent volume of distribution following oral administration is approximately 63 L, indicating that tadalafil is distributed into tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:89a33a41-0f01-4f29-8b2f-769d649fbdcb (opens source in a new tab)
Tadalafil label
Version not recorded · Effective date not recorded
Distribution — The mean apparent volume of distribution following oral administration is approximately 63 L, indicating that tadalafil is distributed into tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:a0f728b6-2cc6-cb65-e053-2a95a90ab142 (opens source in a new tab)
Tadalafil label
Version not recorded · Effective date not recorded
Distribution — The mean apparent volume of distribution following oral administration is approximately 63 L, indicating that tadalafil is distributed into tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:affacb88-4af3-4ce9-961b-7fc37b169e9a (opens source in a new tab)
Tadalafil label
Version not recorded · Effective date not recorded
Distribution — The mean apparent volume of distribution following oral administration is approximately 63 L, indicating that tadalafil is distributed into tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:2c4108c6-9014-4bd8-e063-6294a90a88fa (opens source in a new tab)
Tadalafil label
Version not recorded · Effective date not recorded
Distribution — The mean apparent volume of distribution following oral administration is approximately 63 L, indicating that tadalafil is distributed into tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:51f87c9b-038c-4793-b0d5-5359ae231074 (opens source in a new tab)
Tadalafil label
Version not recorded · Effective date not recorded
Distribution — The mean apparent volume of distribution following oral administration is approximately 63 L, indicating that tadalafil is distributed into tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:a7b3937e-ff03-436a-a5d4-92a4771034b6 (opens source in a new tab)
Tadalafil label
Version not recorded · Effective date not recorded
Distribution — The mean apparent volume of distribution following oral administration is approximately 63 L, indicating that tadalafil is distributed into tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:add6afb8-d38c-47a2-8c35-d5940667bb0c (opens source in a new tab)
Tadalafil label
Version not recorded · Effective date not recorded
Distribution — The mean apparent volume of distribution following oral administration is approximately 63 L, indicating that tadalafil is distributed into tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:34684fe8-9bf3-47fd-e063-6394a90ac80f (opens source in a new tab)
Tadalafil label
Version not recorded · Effective date not recorded
Distribution — The mean apparent volume of distribution following oral administration is approximately 63 L, indicating that tadalafil is distributed into tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:66e24ced-0008-40cb-b242-9d9add1f665c (opens source in a new tab)
Tadalafil label
Version not recorded · Effective date not recorded
Distribution — The mean apparent volume of distribution following oral administration is approximately 63 L, indicating that tadalafil is distributed into tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:168a135b-1454-4def-9b03-c9a470bfcb5f (opens source in a new tab)
Tadalafil label
Version not recorded · Effective date not recorded
Distribution - The mean apparent volume of distribution following oral administration is approximately 63 L, indicating that tadalafil is distributed into tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:b96ae7f1-7d4a-a211-e053-2995a90ab6e2 (opens source in a new tab)
Tadalafil label
Version not recorded · Effective date not recorded
Distribution — The mean apparent volume of distribution following oral administration is approximately 63 L, indicating that tadalafil is distributed into tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:491cb72b-71f2-4df9-99f8-c02d93500103 (opens source in a new tab)
Tadalafil label
Version not recorded · Effective date not recorded
Distribution — The mean apparent volume of distribution following oral administration is approximately 63 L, indicating that tadalafil is distributed into tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:7e4cdac1-42cc-4038-a86b-4890962ed806 (opens source in a new tab)
Tadalafil label
Version not recorded · Effective date not recorded
Distribution — The mean apparent volume of distribution following oral administration is approximately 63 L, indicating that tadalafil is distributed into tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:90f38460-62ad-492e-a3da-403d5a5a5d86 (opens source in a new tab)
Tadalafil label
Version not recorded · Effective date not recorded
Distribution — The mean apparent volume of distribution following oral administration is approximately 63 L, indicating that tadalafil is distributed into tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:a2e7f393-5cfc-45e5-b87d-9e8abc8e4355 (opens source in a new tab)
Tadalafil label
Version not recorded · Effective date not recorded
Distribution — The mean apparent volume of distribution following oral administration is approximately 63 L, indicating that tadalafil is distributed into tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:7dfb450b-4d39-40e7-b115-9a96023052a0 (opens source in a new tab)
Tadalafil label
Version not recorded · Effective date not recorded
Distribution —The mean apparent volume of distribution following oral administration is approximately 63 L, indicating that tadalafil is distributed into tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:ff3c7dd3-2dcc-498c-a121-1e2aa62c7a97 (opens source in a new tab)
Tadalafil label
Version not recorded · Effective date not recorded
Distribution — The mean apparent volume of distribution following oral administration is approximately 63 L, indicating that tadalafil is distributed into tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:00cbc656-768d-4995-bb6d-a0d4b32a248c (opens source in a new tab)
Tadalafil label
Version not recorded · Effective date not recorded
Distribution — The mean apparent volume of distribution following oral administration is approximately 63 L, indicating that tadalafil is distributed into tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:bce03930-14c5-401f-ad17-06b7709983bc (opens source in a new tab)
Tadalafil label
Version not recorded · Effective date not recorded
Distribution — The mean apparent volume of distribution following oral administration is approximately 63 L, indicating that tadalafil is distributed into tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:24b82a6a-1b7e-42e6-b29b-41d4ee4d525f (opens source in a new tab)
Tadalafil label
Version not recorded · Effective date not recorded
Distribution — The mean apparent volume of distribution following oral administration is approximately 63 L, indicating that tadalafil is distributed into tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:31f5dc06-50f8-47cf-e063-6294a90ad5fb (opens source in a new tab)
Tadalafil label
Version not recorded · Effective date not recorded
Distribution — The mean apparent volume of distribution following oral administration is approximately 63 L, indicating that tadalafil is distributed into tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:7976c4ec-ecc4-4a49-a4fe-f990aece2d3c (opens source in a new tab)
Tadalafil label
Version not recorded · Effective date not recorded
Distribution — The mean apparent volume of distribution following oral administration is approximately 63 L, indicating that tadalafil is distributed into tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:4348b7db-e5b2-4e87-8cdd-674797a18890 (opens source in a new tab)
Tadalafil label
Version not recorded · Effective date not recorded
Distribution — The mean apparent volume of distribution following oral administration is approximately 63 L, indicating that tadalafil is distributed into tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:fa547e3d-455a-4926-9fd9-349930898502 (opens source in a new tab)
Tadalafil label
Version not recorded · Effective date not recorded
Distribution — The mean apparent volume of distribution following oral administration is approximately 63 L, indicating that tadalafil is distributed into tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:dc14daa3-cae9-4751-9034-b0e9c18054b4 (opens source in a new tab)
Tadalafil label
Version not recorded · Effective date not recorded
Distribution — The mean apparent volume of distribution following oral administration is approximately 63 L, indicating that tadalafil is distributed into tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:248a4705-1403-e94a-e063-6294a90a3544 (opens source in a new tab)
Tadalafil label
Version not recorded · Effective date not recorded
Distribution — The mean apparent volume of distribution following oral administration is approximately 63 L, indicating that tadalafil is distributed into tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:22b8a2e3-d1b8-f193-45fa-77cc62a1b941 (opens source in a new tab)
Tadalafil label
Version not recorded · Effective date not recorded
Distribution — The mean apparent volume of distribution following oral administration is approximately 63 L, indicating that tadalafil is distributed into tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:a73b0e6f-09fc-42d6-a678-1409ce746bd1 (opens source in a new tab)
Tadalafil label
Version not recorded · Effective date not recorded
Distribution - The mean apparent volume of distribution following oral administration is approximately 63 L, indicating that tadalafil is distributed into tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:2cad2167-dbd1-4df8-b407-b270487d027b (opens source in a new tab)
Tadalafil label
Version not recorded · Effective date not recorded
Distribution — The mean apparent volume of distribution following oral administration is approximately 63 L, indicating that tadalafil is distributed into tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f2a132af-d75e-2ca0-e053-2a95a90a332e (opens source in a new tab)
Tadalafil label
Version not recorded · Effective date not recorded
Distribution The mean apparent volume of distribution following oral administration is approximately 63 L, indicating that tadalafil is distributed into tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:ae801b15-0462-44af-99a4-affe3eed899a (opens source in a new tab)
Tadalafil label
Version not recorded · Effective date not recorded
Distribution — The mean apparent volume of distribution following oral administration is approximately 63 L, indicating that tadalafil is distributed into tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:78509a43-a907-4359-9022-f38c4f765880 (opens source in a new tab)
Tadalafil label
Version not recorded · Effective date not recorded
Distribution — The mean apparent volume of distribution following oral administration is approximately 63 L, indicating that tadalafil is distributed into tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:82dfea4c-9fe5-438a-917f-8f7d395ee8ca (opens source in a new tab)
Tadalafil label
Version not recorded · Effective date not recorded
Distribution — The mean apparent volume of distribution following oral administration is approximately 63 L, indicating that tadalafil is distributed into tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f8def23c-55ea-4796-9735-dbcb25104835 (opens source in a new tab)
Tadalafil label
Version not recorded · Effective date not recorded
Distribution — The mean apparent volume of distribution following oral administration is approximately 63 L, indicating that tadalafil is distributed into tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:48892acb-43bb-a4d8-e063-6394a90a5d61 (opens source in a new tab)
Tadalafil label
Version not recorded · Effective date not recorded
Distribution — The mean apparent volume of distribution following oral administration is approximately 63 L, indicating that tadalafil is distributed into tissues.
77 L
- Numeric value
- 77
- Unit
- L
- Source records
- 16
Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.
Show all 16 source records
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:a0ecc7cf-20dd-485a-b4dd-1bbc587280a7 (opens source in a new tab)
Tadalafil label
Version not recorded · Effective date not recorded
Distribution — The mean apparent volume of distribution following oral administration is approximately 77 L, indicating that tadalafil is distributed into tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:84cb16c8-30ab-49f2-a6df-ec3c97bf6284 (opens source in a new tab)
Tadalafil label
Version not recorded · Effective date not recorded
Distribution — The mean apparent volume of distribution following oral administration is approximately 77 L, indicating that tadalafil is distributed into tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:efa03afa-c412-4b31-bf26-7c3a6f7311af (opens source in a new tab)
Tadalafil label
Version not recorded · Effective date not recorded
Distribution The mean apparent volume of distribution following oral administration is approximately 77 L, indicating that tadalafil is distributed into tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:cec49f6c-71f1-4de7-b515-1612ae16e5db (opens source in a new tab)
Tadalafil label
Version not recorded · Effective date not recorded
Distribution — The mean apparent volume of distribution following oral administration is approximately 77 L, indicating that tadalafil is distributed into tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:dc0a6a03-5ef1-4507-b888-5b559653c3e9 (opens source in a new tab)
Tadalafil label
Version not recorded · Effective date not recorded
Distribution — The mean apparent volume of distribution following oral administration is approximately 77 L, indicating that tadalafil is distributed into tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:93dd604f-8f38-4600-afe8-0fcc92fd2497 (opens source in a new tab)
Tadalafil label
Version not recorded · Effective date not recorded
Distribution — The mean apparent volume of distribution following oral administration is approximately 77 L, indicating that tadalafil is distributed into tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:88132351-7fee-47ef-8007-ef2777543299 (opens source in a new tab)
Tadalafil label
Version not recorded · Effective date not recorded
Distribution — The mean apparent volume of distribution following oral administration is approximately 77 L, indicating that tadalafil is distributed into tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:9489b635-385e-4a05-be02-df39fcafebe3 (opens source in a new tab)
Tadalafil label
Version not recorded · Effective date not recorded
Distribution — The mean apparent volume of distribution following oral administration is approximately 77 L, indicating that tadalafil is distributed into tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:3c1c2136-099f-6232-e063-6294a90a6975 (opens source in a new tab)
Tadalafil label
Version not recorded · Effective date not recorded
Distribution — The mean apparent volume of distribution following oral administration is approximately 77 L, indicating that tadalafil is distributed into tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:cf6fc925-ad20-4ed0-9356-15d24afa8d0b (opens source in a new tab)
Tadalafil label
Version not recorded · Effective date not recorded
Distribution — The mean apparent volume of distribution following oral administration is approximately 77 L, indicating that tadalafil is distributed into tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:0afd0728-256a-293b-e063-6394a90a3c5f (opens source in a new tab)
Tadalafil label
Version not recorded · Effective date not recorded
Distribution — The mean apparent volume of distribution following oral administration is approximately 77 L, indicating that tadalafil is distributed into tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:2faa7a55-3054-456b-8465-6ea6dc1c0aa9 (opens source in a new tab)
Tadalafil label
Version not recorded · Effective date not recorded
Distribution - The mean apparent volume of distribution following oral administration is approximately 77 L, indicating that tadalafil is distributed into tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:fceb8aaf-b4eb-4004-8ca4-f004eac6b314 (opens source in a new tab)
Tadalafil label
Version not recorded · Effective date not recorded
Distribution — The mean apparent volume of distribution following oral administration is approximately 77 L, indicating that tadalafil is distributed into tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:7a909b25-3772-403e-a5fe-e4a040293fb7 (opens source in a new tab)
Tadalafil label
Version not recorded · Effective date not recorded
Distribution — The mean apparent volume of distribution following oral administration is approximately 77 L, indicating that tadalafil is distributed into tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:ff61b237-be8e-461b-8114-78c52a8ad0ae (opens source in a new tab)
Tadalafil label
Version not recorded · Effective date not recorded
Distribution — The mean apparent volume of distribution following oral administration is approximately 77 L, indicating that tadalafil is distributed into tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:61955171-ca57-e300-1983-9472a56ca976 (opens source in a new tab)
Tadalafil label
Version not recorded · Effective date not recorded
Distribution — The mean apparent volume of distribution following oral administration is approximately 77 L, indicating that tadalafil is distributed into tissues.
Projected row 1446
- Medicine slug
- tafasitamab-cxix
- Compared field
- halfLife
- Comparison state
- insufficient_context
- Reason codes
- STRUCTURED_CONTEXT_MISSING
- Documents examined
- 2
- Source count
- 2
- Agreement rate
- 0.5
- Recorded readings
13.4 days
- Numeric value
- Not parsed
- Unit
- Not recorded
- Source records
- 1
Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.
Show all 1 source records
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:9e0a220b-517f-4c86-b581-ffbab493fb58 (opens source in a new tab)
Tafasitamab-Cxix label
Version not recorded · Effective date not recorded
Elimination Tafasitamab-cxix estimated elimination half-life was 13.4 days (31.7%) with an apparent clearance of 0.44 L/day (29.2%).
17 days
- Numeric value
- Not parsed
- Unit
- Not recorded
- Source records
- 1
Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.
Show all 1 source records
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:ec13ac6b-bfde-4e84-907a-83bd69584d95 (opens source in a new tab)
Tafasitamab-Cxix label
Version not recorded · Effective date not recorded
Elimination The clearance of tafasitamab-cxix was 0.41 L/day (CV: 32%) and terminal elimination half-life was 17 days (95% CI: 15, 18 days).
Projected row 1447
- Medicine slug
- tafasitamab-cxix
- Compared field
- volumeOfDistribution
- Comparison state
- insufficient_context
- Reason codes
- STRUCTURED_CONTEXT_MISSING
- Documents examined
- 2
- Source count
- 2
- Agreement rate
- 0.5
- Recorded readings
7.11 L
- Numeric value
- 7.11
- Unit
- L
- Source records
- 1
Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.
Show all 1 source records
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:9e0a220b-517f-4c86-b581-ffbab493fb58 (opens source in a new tab)
Tafasitamab-Cxix label
Version not recorded · Effective date not recorded
C max (mcg/mL) C trough (mcg/mL) End of weekly dosing (end of Cycle 3) (N = 367) 315 (30.3%) 489 (22.8%) 226 (38.5%) Steady state Steady state values are approximated at Cycle 6 with every 2-week dosing (N = 285) 185 (32.5%) 375 (20.8%) 112 (44.8%) Distribution Tafasitamab-cxix steady state total volume of distribution was 7.11 L (29.7%).
9.3 L
- Numeric value
- 9.3
- Unit
- L
- Source records
- 1
Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.
Show all 1 source records
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:ec13ac6b-bfde-4e84-907a-83bd69584d95 (opens source in a new tab)
Tafasitamab-Cxix label
Version not recorded · Effective date not recorded
Distribution The total volume of distribution for tafasitamab-cxix was 9.3 L (95% CI: 8.6, 10 L).
Projected row 1448
- Medicine slug
- tafenoquine
- Compared field
- halfLife
- Comparison state
- insufficient_context
- Reason codes
- STRUCTURED_CONTEXT_MISSING
- Documents examined
- 3
- Source count
- 2
- Agreement rate
- 0.5
- Recorded readings
15 days
- Numeric value
- Not parsed
- Unit
- Not recorded
- Source records
- 1
Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.
Show all 1 source records
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:5cf989d5-36f5-4561-a30b-9fcb9deb6b6a (opens source in a new tab)
Tafenoquine label
Version not recorded · Effective date not recorded
The average terminal half-life is approximately 15 days.
16.5 days
- Numeric value
- Not parsed
- Unit
- Not recorded
- Source records
- 1
Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.
Show all 1 source records
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:299e49d8-470f-4779-a010-4a1ee0e0c6cd (opens source in a new tab)
Tafenoquine label
Version not recorded · Effective date not recorded
The mean terminal half-life following administration of ARAKODA is approximately 16.5 days (range: 10.8 days to 27.3 days) in healthy adult subjects.
Projected row 1449
- Medicine slug
- tafenoquine
- Compared field
- volumeOfDistribution
- Comparison state
- insufficient_context
- Reason codes
- STRUCTURED_CONTEXT_MISSING
- Documents examined
- 3
- Source count
- 2
- Agreement rate
- 0.5
- Recorded readings
1,600 L
- Numeric value
- 1,600
- Unit
- L
- Source records
- 1
Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.
Show all 1 source records
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:5cf989d5-36f5-4561-a30b-9fcb9deb6b6a (opens source in a new tab)
Tafenoquine label
Version not recorded · Effective date not recorded
The apparent oral volume of distribution is ~1,600 L.
2470 L
- Numeric value
- 2,470
- Unit
- L
- Source records
- 1
Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.
Show all 1 source records
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:299e49d8-470f-4779-a010-4a1ee0e0c6cd (opens source in a new tab)
Tafenoquine label
Version not recorded · Effective date not recorded
The apparent volume of distribution of tafenoquine in healthy adult subjects is 2470 L [Inter-Individual Variability (IIV): 24.1 %].
Projected row 1450
- Medicine slug
- talazoparib
- Compared field
- proteinBinding
- Comparison state
- agree
- Reason codes
- COMPATIBLE_VALUES_OVERLAP
- Documents examined
- 4
- Source count
- 4
- Agreement rate
- 1
- Recorded readings
74%
- Numeric value
- 74
- Unit
- %
- Source records
- 4
Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.
Show all 4 source records
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f2423edd-6d24-495c-aec1-c2f457f08d9a (opens source in a new tab)
Talazoparib label
Version not recorded · Effective date not recorded
In vitro , protein binding of talazoparib is 74% and is independent of talazoparib concentration.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:c6fd147f-a77e-4a0b-9280-e82ecc41b4be (opens source in a new tab)
Talazoparib label
Version not recorded · Effective date not recorded
In vitro , protein binding of talazoparib is 74% and is independent of talazoparib concentration.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:13839d4f-6acf-4ffb-a128-79df59319273 (opens source in a new tab)
Talazoparib label
Version not recorded · Effective date not recorded
In vitro , protein binding of talazoparib is 74% and is independent of talazoparib concentration.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:b653221e-971f-4452-92d4-797924f1ff59 (opens source in a new tab)
Talazoparib label
Version not recorded · Effective date not recorded
In vitro , protein binding of talazoparib is 74% and is independent of talazoparib concentration.
Access
Query or download the projection
GET /api/datasets/source-consensus?limit=10&offset=1440Allowed query parameters
- q
- Case-insensitive text search over the public fields named for this dataset.
- state
- Exact comparability state.Values: agree, differ, not_comparable, insufficient_context
- field
- Exact recorded field key.Values: bioavailability, halfLife, proteinBinding, tMax, volumeOfDistribution
- limit / offset
- Pagination is required. limit is at most 200; offset is bounded. Set format=csv for the same projected page as a download.
Reuse and corrections
Keep the boundary attached
CC BY 4.0 applies to RNAWiki licenses its selection, schema, structure, and derived projection. Quoted source passages and third-party records retain their original rights.
Cite RNAWiki, this dataset identifier, and the generated date. Keep the “does not mean” statement with any downstream display so a corpus measurement is not mistaken for medical advice.